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INTRODUCTION 
Headache is a leading reason for medical consultation and 
particularly for neurological consultation. A tremendous range of 
disorders can present with headaches. Given the range of disorders that 
are implicated in manifesting as headache, a detailed analysis and 
interpretation of  the pattern of headache would be of immense help in 
distinguishing the rarer life threatening causes of secondary headaches 
from the more common primary headaches. Previous studies have 
mentioned that 86% had primary headaches that were classifiable, 11% 
were unclassifiable and 3% had secondary headaches 1.  Amongst the 
secondary headaches, this study is planned mainly  to analyse the pattern 
of the  secondary headaches due to brain neoplasm. 
Classification of Brain tumours 
Brain tumours are a diverse group of neoplasms arising from 
different cells within the central nervous system (CNS) or from systemic 
tumours that have metastasized to the CNS. Brain tumours include a 
number of histologic types with markedly different tumour growth rates. 
They are broadly classified into primary and secondary metastatic 
tumours 
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(I)  Primary neuroepithelial tumours: 
- Diffuse astrocytoma( Fibrillary, gemistocytic , protoplasmic), 
anaplastic asrocytoma, Circumscrined astrocytoms 
- Glioblastoma 
- Oligodendroglioma 
- Ependymoma, subependymoma, myxopapillary ependymoma 
- Choroid plexus tumours 
- Primitive neuroectodermal tumours 
- Mesangial/ extraxial: 
- Meningiomas ( including atypical and anaplastic) 
- Heamangiopericytomas 
- Nerve sheath tumours: 
Schwanomas 
Neurofibromas 
- Miscellaneous tumours: 
CNS lymphomas 
Germcell tumours 
Heamangioblastomas 
Craniopharyngiomas 
Epidermoid and colloid cysts 
(II)  Metastatic tumours. 
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MECHANISM OF HEADACHE   
Headache arises from activation of pain-sensitive intracranial 
structures. In the 1930s, Ray and Wolfe 2, identified intracranial 
components were pain-sensitive and mapped the pattern of pain referral 
based on studies in which various intracranial structures were stimulated 
during intracranial surgery performed during local anesthesia. 
The brain parenchyma is insensitive to pain. The intracranial pain-
sensitive structures include the arteries of the circle of Willis and the first 
few centimeters of their medium-sized branches, meningeal (dural) 
arteries, large veins and dural venous sinuses, and portions of the dura  
near blood vessel including the tentorium and the diaphragma sellae. 
Pain-sensitive structures that are external to the skull cavity include the 
external carotid artery and its branches, periosteum of the skull, scalp and 
neck muscles, skin and cutaneous nerves, cervical nerves and nerve roots, 
mucosa of sinuses, and teeth. Pain from these structures is carried by 
cranial nerves (CN) V, VII, IX, and X. 2,3. 
  Inflammation, traction, compression, malignant infiltration, and 
other disturbances of pain-sensitive structures lead to headache. 
Superficial structures tend to refer pain locally, whereas deeper-seated 
lesions may refer pain imprecisely. Within the cranial vault, nociceptive 
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signals reach the central nervous system (CNS) largely by way of the first 
division of the trigeminal nerve (CN V), and therefore an occipital lobe 
tumour may refer pain to the frontal head region. Infratentorial lesions 
tend to refer pain posteriorly because this compartment is innervated by 
the second and third cervical nerve roots, which also supply the back of 
the head. However, posterior lesions or cervical spine pathological 
conditions may also produce frontal headache, because the caudal portion 
of the trigeminal nucleus extends down as far as the dorsal horn at the C3 
level. Impulses arriving from C2 to C3 converge on neurons within  
the trigeminal nucleus and may refer pain to the somatic distribution  
of CN VI.  
Afferent pain impulses into the trigeminal nucleus are modulated 
by descending facilitatory and inhibitory input from brainstem structures, 
including the periaqueductal gray matter, rostral ventromedial medulla, 
locus ceruleus, and dorsal raphe nuclei. Opioids diminish pain perception 
by activating the inhibitory systems, whereas fear, anxiety, and overuse 
of analgesics may activate the facilitatory systems, thereby aggravating 
pain.  
Traction on the large blood vessels and dura as well as direct 
compression of cranial and cervical nerve fibers by the tumour itself are 
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the likely mechanisms for headaches attributed to brain tumours2,3. 
Tumours and other mass lesions can cause headache by direct pressure on 
any of the above structures. Pain arising from the intracranial cavity is a 
form of visceral pain, and therefore referred to more superficial 
structures; it is not perceived as coming directly from the compressed 
region. In general, unilateral lesions refer pain ipsilaterally, supratentorial 
lesions refer pain to the frontal regions, and posterior fossa masses refer 
pain to the occiput4.  However, these associations have poor localizing 
value. As an example, in a study that evaluated 37 patients with 
infratentorial tumours, 73 percent of patients had headache in the frontal, 
temporal, and/or parietal regions, while nuchal and occipital pain 
occurred in only 27 percent 11. 
Acute or severe headache from a brain tumour can potentially be 
caused by elevated intracranial pressure resulting from hydrocephalus, 
mass effect of the tumour itself, or hemorrhage into or around the tumour 
5. A tumour can distort or displace structures distant from its locale, 
resulting in referred pain that does not correspond with its location.  
In such cases of "distant traction," elevated intracranial pressure may be 
the cause of the headache6. However, the relationship between elevated 
intracranial pressure and headache in brain tumour remains uncertain 7.  
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Headache is initially seen in about 20 percent of patients with brain 
tumour, and headache occurs during the course of the disease in about 48 
to 60 percent12,13.   A history of pre-existing headache is a probable risk 
factor for headache associated with brain tumour12 , though this may 
apply only to a longstanding primary headache history and not to a 
remote history13. 
The prevalence of intracranial neoplasm is exceedingly low  in 
patients with headache without neurological signs 14. But the prevalence 
of intracranial involvement is relatively high in patients with known 
systemic malignancy 23. 
The features of brain tumour headache are generally nonspecific 
and vary widely with tumour location, size, and rate of growth 5,13,14  .The 
headache is usually bilateral, but can be on the side of the tumour 15 . 
Supratentorial tumours impinging on structures innervated by the 
ophthalmic division of the trigeminal nerve may produce a 
frontotemporal headache, while posterior fossa tumours compressing the 
glossopharyngeal and vagus nerves can cause occipitonuchal pain. There 
is generally little radiation, except in posterior fossa tumours. Nausea 
and/or vomiting accompany the headache in 40 to 60 percent of adult 
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patients 11,12.  Headache exacerbation with Valsalva, change in position, 
or exertion occurs in a substantial minority of patients. 
Although headache is commonly seen with brain tumour, it is 
rarely seen as an isolated symptom. In most cases, it is associated with 
other neurologic symptoms such as seizures or focal weakness during the 
course if not at the onset. Among adults, only 2 to 16 percent of patients 
with brain tumour present with headache alone 9,12,19,28 . Isolated headache 
of more than 10 weeks duration is seldom caused by brain tumour 19. 
Tumour-related headaches tend to be worse at night and may awaken the 
patient. This nocturnal pattern is thought to be due in part to transient 
increases in PCO2, a potent vasodilator, during sleep. Other possible 
physiologic explanations include recumbency and decreased cerebral 
venous return. The classic "brain tumour triad," comprising nocturnal or 
early morning occurrence, nausea/vomiting, and severe nature, has not 
been borne out as a typical pattern in modern studies.  
Tumour location and pathology play a role in the presentation of 
the headache. Primary brain tumours and metastatic tumours are equally 
likely to cause headache12,20. In general, slow-growing supratentorial 
tumours, such as low-grade gliomas, cause headache less frequently than 
tumours with more rapid growth. With slower-growing tumours, seizures 
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are more common than headaches21. Meningiomas are usually slowly 
progressive, and cause headaches significantly less often than gliomas. 
Headache occurs in approximately one-third of patients with 
supratentorial meningiomas12, 15. The meninges may also be involved in 
diffuse tumour infiltration (leptomeningeal carcinomatosis), which results 
in a generalized headache. 
Tumours in the posterior fossa, such as medulloblastomas and 
ependymomas, cause headache in 60 to 83 percent of patients, and earlier 
in the clinical course than supratentorial ones 20,30. Guillamo etal 31 in a 
study of brainstem gliomas, excluding ependymomas, found only 44 
percent of patients with headache . The posterior fossa, location seems to 
be a more important determinant of headache than tumour type, as  
posterior fossa lesions tend to obstruct cerebrospinal fluid pathways early 
and lead to increased intracranial pressure 4.  Headache is the presenting 
symptom of posterior fossa tumours in most cases, with the notable 
exception of cerebellopontine angle tumours. Most are vestibular 
schwannomas, which usually present with hearing loss or tinnitus before 
the onset of headache. 
Sellar and parasellar tumours in adults do not commonly present 
with headache, despite the sensitivity of the diaphragma sellae to pain27. 
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Primary lesions in sellar area arise predominantly from the pituitary, the 
optic nerve and hypothalamus, the meninges and surrounding 
mesenchymal structures. These commonly are pituitary adenomas and 
craniopharyngiomas, presenting with visual or endocrine symptoms. 
Nevertheless, headache is a common accompaniment of pituitary tumours 
33. Headaches are classically retro-orbital or bifrontal or frontotemporal. 
They tend to be worse on waking. Sudden catastrophic headaches may 
result from pituitary apoplexy. Very large pituitary tumours and 
craniopharygiomas may cause obstruction of CSF, resulting in 
hydrocephalus. Levy et al 17 in his study with pituitary tumours, stated the 
headache was  seen in 70 percent, but there was no relationship between 
headache features and pituitary volume  and the presenting phenotype is 
likely to be governed by a combination of factors, including tumour 
activity, relationship to the cavernous sinus and patient predisposition to 
headache17.   
The clinical manifestations of ventricular tumours  depend on the 
tumour size and location, and only when the tumour blocking the 
circulation of cerebrospinal fluid pathway, or when the tumour  
encroaches around the brain tissue, produces corresponding symptoms 
and signs, such as intracranial hypertension and lesions. 
10 
 
The common symptoms of lateral cerebral ventricle Tumour include 
Intracranial hypertension (headache), positioning signs, Mental disorders, 
papilledema and seizures. 
When the intra ventricular tumour is small or when the cycling of 
cerebrospinal fluid is maintained, the patient may be completely without 
any apparent symptoms. Cerebrospinal fluid circulation is affected when 
obstacles (holes between rooms blocked some intraventricular 
obstruction) to flow happens, producing intracranial hypertension which 
is clinically manifested as a headache. Headache is the first symptom for 
most patients, according to data in order to headache symptoms as the 
first lateral ventricle tumours account for about 92.5% of patients. They 
mostly have paroxysmal headache, intermittent or paroxysmal increase. 
When the room between the holes or intraventricular part of (the next 
corner or angle) when the blockage caused by obstructive hydrocephalus, 
due to the rapid expansion of the ventricle, causes unbearable headache 
with severe nausea and vomiting. This sudden increase in intracranial 
pressure may lead to coma or even death due to herniation. Tumour in the 
side of the indoor activities have a certain degree, offen showed sudden 
valve-like obstruction of cerebrospinal fluid circulation pathway, 
resulting in acute increase of intracranial pressure, resulting in  headache. 
When the body or head position changes causing lifting of 
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intraventricular obstruction, the patient can quickly stop the headache. 
Such as re-obstruction, then the recurrence of headaches, such attacks 
could be repeated many times. Therefore a small number of patients 
experience attacks from time to time before the amount of flexion was hit 
or prone position. 
Colloid cysts of the third ventricle are benign tumours that may 
cause brief, severe headache reflecting blockage of the cerebrospinal fluid 
pathway by the tumour in a ball-valve mechanism, worsened or relieved 
by changes in position33. Third ventricular ependymomas are rare 
tumours. The presenting symptoms included headache, ataxia, vertigo, 
Parinaud's syndrome and obstructive hydrocephalus 34 . 
  Cavernoma is a vascular abnormality of the central nervous 
system. It consists of a cluster of abnormal, dilated vessels. Cavernomas 
can be found in any region of the brain. Headaches may be a heralding 
symptom in cavernous malformation. 6-10% of patients with a 
cavernoma will report headaches as an accompanying symptom. Up to 
25% of patients will present with a hemorrhage. The headache starts 
suddenly and may be followed by nausea, neurological problems or a 
decreasing level of consciousness. Sometimes a bleed may be very small 
and produce very mild or no symptoms at all. 
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 Brain metastases are the most common intracranial tumours in 
adults, accounting for significantly more than one-half of brain tumours. 
In patients with systemic malignancies, brain metastases occur in 10 to 30 
percent of adults and 6 to 10 percent of children 35. The incidence of brain 
metastases may be increasing, due to both improved detection of small 
metastases by magnetic resonance imaging (MRI) and better control of 
extracerebral disease resulting from improved systemic therapy. 
  In adults, the most common primary tumours responsible for brain 
metastases are carcinomas, and include lung, breast, kidney, and 
colorectal cancers, and melanoma. In contrast, carcinomas of the prostate, 
esophagus, and oropharynx and non-melanoma skin cancers rarely 
metastasize to the brain.  
This was illustrated in two large series, one from the Metropolitan 
Detroit Cancer Surveillance System and the other from a Dutch series 36. 
The incidence of brain metastases detected was : 
• Lung — 16 to 20 percent  
• Melanoma — 7 percent  
• Renal cell cancer — 7 to 10 percent  
• Breast cancer — 5 percent  
• Colorectal cancer — 1 to 2 percent 
The most common mechanism of metastasis to the brain is by 
hematogenous spread 37 .Metastases are usually located directly at the 
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junction of the gray matter and white matter where blood vessels decrease 
in diameter and act as a trap for clumps of tumour cells . Brain metastases 
also tend to be more common at the terminal "watershed areas" of arterial 
circulation. The distribution of metastases roughly follows the relative 
weight and blood flow in each area 38 : 
• Cerebral hemispheres — approximately 80 percent  
• Cerebellum — 15 percent  
• Brainstem — 5 percent 
Different primary tumours may have a predilection for metastasis 
to different areas within the brain. For example, pelvic (prostatic and 
uterine) and gastrointestinal tumours more commonly metastasize to the 
posterior fossa 38, while metastases of small cell carcinoma of the lung are 
equally distributed in all regions of the brain. The reasons for these 
differences are unclear but may be due to cell surface properties of the 
metastatic cells and the endothelium within the central nervous system 
(CNS) vasculature. 
Headaches occur in approximately 40 to 50 percent of patients with 
brain metastases. The frequency is higher when multiple lesions are 
present or a metastasis is located in the posterior fossa. Headache was 
present in 48 percent and equally affected those with primary and 
metastatic tumours 12.  
14 
 
AIM OF THE STUDY 
This study is aimed to analyse the clinical profile of secondary 
headache in patients with brain tumour. 
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REVIEW OF LITERATURE 
A secondary headache in patients with a brain tumour is defined in 
The International Classification of Headache Disorders (ICHD-II) (1) in 
subchapter 7.4.  
As per the criteria of International headache society,IHS 2004 2nd 
edition.8 
If a new headache occurs for the first time in close temporal 
relationship to another disorder that is known cause of headache this 
headache is coded according to the causative disorder as a secondary 
headache. When a pre-existing headache is made worse in close temporal 
relation to another disorder  that is a known cause of headache both the 
types are a possibility. Factors that support secondary headache are very 
close temporal relation to the causative disorder, worsening of the pre-
existing chronic headache, causative factor capable of aggravating 
headache, improvement or disappearance of headache after management 
of causative disorder. 
The last criteria for secondary headache requires that headache 
greatly improves or resolves within a specific period after relief from the 
causative disorder.  
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Persistance of headache beyond a period of 3 months  after 
occurrence, remission or cure of the causative  disorder could be named 
chronic headache attributable to the disorder. 
The International classification of Headache  disorders has coded  
headache with brain tumours as follows 
IHS 7.4 , WHO (G44.82)  
(A)  Headache attributable to intracranial neoplasm 
Diagnositc criteria: 
A.  Headache with atleast one of the following characteristics and 
fulfilling criteria C and D 
1.progressive 
2. localised 
3. worse in the morning 
4.agravated by coughing or bending forward. 
B.  Intracranial neoplasm shown by imaging 
C.  Haedache develops in temporal( and spatial ) relationship to the  
neoplasm. 
D.  Headache resolves within 7 days after surgical removal or  volume 
reduction of the neoplasm or treatment with steroids. 
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(B)  For headache attributed to carcinomatous meningitis, 
diagnostic criteria are the following : 
A)  Diffuse or localized headache fulfilling criterion C  
B)  Carcinomatous meningitis proven by (repeated) cerebrospinal fluid 
examination and/or dural enhancement on MRI  
C)  Headache develops and/or deteriorates with advancing disease; 
however, the headache may improve temporarily with intrathecal 
chemotherapy or glucocorticoid treatment. 
(C)  For headache attributed to hypothalamic or pituitary hyper- or 
hyposecretion, diagnostic criteria are as follows : 
A)  Bilateral, frontotemporal and/or retro-orbital headache fulfilling 
criteria C and D  
B)  At least one of the following:  
1. Prolactin, growth hormone and adrenocorticotropic hormone 
hypersecretion associated with microadenomas <10mm in 
diameter  
2. Disorder of temperature regulation, abnormal emotional 
state, altered thirst and appetite and change in level of 
consciousness associated with hypothalamic tumour 
C)  Headache develops during endocrine abnormality  
D) Headache resolves within three months after surgical resection or 
specific and effective medical therapy. 
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(D)  For headache attributed to increased intracranial pressure or 
hydrocephalus caused by neoplasm, the following diagnostic 
criteria apply : 
A)  Diffuse non-pulsating headache with at least one of the following 
characteristics and fulfilling criteria C and D: 
Associated with nausea and/or vomiting  
1. Worsened by physical activity and/or manoeuvres known to 
increase intracranial pressure (such as Valsalva manoeuvre, 
coughing or sneezing)  
2. Occurring in attack-like episodes (Onset of headache can be 
sudden (thunderclap headache) and, in such cases, associated 
with loss of consciousness) 
B) Space-occupying intracranial tumour demonstrated by CT or MRI 
and causing hydrocephalus (eg, colloid cyst of the third ventricle)  
C)  Headache develops and/or deteriorates in close temporal relation to 
the hydrocephalus  
D)  Headache improves within seven days after surgical removal or 
volume reduction of tumour. 
  In studies of unselected tumours, headache prevalence ranges from 
48% to 71% (Forsyth and Posner 1993 12 ; Pfund et al 1999 11; Davies and 
Clarke 2004  28 ; Schankin et al 2007 9; Valentinis et al 201013). The 
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prevalence has remained relatively constant despite changes in 
neuroimaging techniques and greater availability. Headache was reported 
in only 33% of children in a meta-analysis of later papers from 1991 to 
2005 reporting signs and symptoms of childhood brain tumours at 
presentation (Childhood Brain Tumour Consortium 1991 16 ). 
Headache pain ranges from a dull ache to a pressure or tightening 
or a throbbing or shooting pain (Forsyth and Posner 1993 12; Pfund et al 
1999 11; Schankin et al 2007 9; Valentinis et al 2010 13).  
   The headache pain is usually intermittent, moderate to severe in 
intensity, and progressive (Forsyth and Posner 1993 12; Pfund et al 1999 
11; Schankin et al 92007; Valentinis et al 2010 13).  
Only about a third of patients have nocturnal or morning headaches 
or both, and 20% report headache exacerbation by Valsalva maneuvers 
(Forsyth and Posner 1993 12; Pfund et al 1999 11; Valentinis et al 2010 13). 
 Nausea and vomiting are reported in 18% to 60% of patients 
(Forsyth and Posner 1993 12;  Pfund et al 1999 11; Schankin et al 2007 9 ; 
Valentinis et al 2010 13). 
   Headaches with features of primary headache disorders are found 
in a minority of patients. Migraine-type headaches are reported in up to 
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15%, and these usually have atypical features (Forsyth and Posner 1993 
12; Pfund et al 1999 11; Schankin et al 2007 9; Valentinis et al 2010 13). 
Tension-type headaches were seen in 29% to 39% of patients (Schankin 
et al 2007 9; Valentinis et al 2010 13). 
   Children are more likely than adults to have nocturnal headache or 
headache on awakening. Nausea and vomiting are also more common in 
children than in adults, reported in 72% of children with supratentorial 
tumours and 86% with infratentorial tumours (Childhood Brain Tumour 
Consortium 1991 16). 
   Isolated headache with no other symptoms may be the first 
manifestation of a brain tumour, but it is unusual for patients not to 
develop other symptoms by diagnosis. In adults, only 2% to 8% of 
patients have isolated headache on presentation, and in 1 study of 183 
patients, all patients had developed other symptoms within 10 weeks 
(Vazquez-Barquero et al 1994 19; Schankin et al 2007 9; Valentinis et al 
2010 13). A study of 3,291 children with brain tumours found that less 
than 1% had headache as their sole symptom and less than 3% had no 
neurologic abnormality on examination (Childhood Brain Tumour 
Consortium 1991). In 2006, Wilne and colleagues reported that 41% of 
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200 children with brain tumours had headache at presentation, and all 200 
children had other symptoms and signs (Wilne et al 2006). 
   Headache lateralization does not always predict tumour location. 
Pfund and colleagues have mentioned that headache lateralization 
predicted tumour location in only one third of patients, and 12% of 
patients with unilateral headaches had a contralateral tumour (Pfund et al 
1999 11). In contrast, Forsyth and colleagues had stated that all patients 
with unilateral headache had an ipsilateral tumour (Forsyth and Posner 
1993 12). Frontal headaches were the most unreliable in predicting tumour 
location and were most common (Forsyth and Posner 1993 12; Valentinis 
et al 2010 13). The reported frequency of bilateral headaches ranged from 
18% to 72%. Generalized headache may result from increased 
intracranial pressure (ICP), which can arise either from a large mass or 
from restriction of cerebrospinal fluid outflow causing hydrocephalus. 
(Forsyth and Posner 1993 12; Pfund et al 1999 11). 
   The majority of patients with infratentorial tumours have 
supratentorial headaches only; but if occipital pain is present, an 
infratentorial tumour is more likely. Skull-based tumours were more often 
associated with frontal headache (Pfund et al 1999 11 ; Schankin et al 
2007 9; Valentinis et al 2010 13). 
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The prevalence of headache varied with tumour location: 
intraventricular and midline tumours (92% to 95% had headache), 
infratentorial tumours (70% to 84%), and supratentorial tumours (55% to 
60%) ; Childhood Brain Tumour Consortium 16 1991; Pfund et al 1999 
11;). 
Factors that predict increased risk of headache in patients with 
brain tumour other than location include raised intracranial pressure, 
degree of midline shift, and increasing edema (Forsyth and Posner 1993 
12; Pfund et al 1999 11). The relationship between tumour size and the 
likelihood of headache is uncertain. (Forsyth and Posner et al12 ).  
Valentinis et al 2010 13   have stated that within similar pathologies, 
increased size was associated with increased risk of headache, but others 
studies (Pfund et al 1999 11; Levy et al  2004b 17; Schankin et al 2007 9;) 
have not shown this association. The headache  of brain tumour 
associated headache worsens as the tumour grows  14. 
A prior history of headaches also predicts an increased risk of 
headache with a brain tumour (Forsyth and Posner 1993 12 ; Valentinis et 
al 2010 13). Schankin et al 2007 9 reported that an alteration of headache 
in 82.5% of patients with preexisting headache. 
23 
 
Forty-nine percent of patients with headaches and pituitary 
tumours had a family history of a headache disorder (Levy et al 2005 17). 
   Uncommon headache syndromes  can occur as a symptom of brain 
tumours. Headache is reported in 72% of pituitary tumours (Levy et al 
2004b 17). Trigeminal autonomic cephalgias (TACS) are reported more 
frequently than expected. In a case series of 84 patients, 76% had chronic 
or episodic migraine, 5% had short-lasting unilateral neuralgiform 
headache attacks with conjunctival injection and tearing (SUNCT), 4% 
had cluster headache, 1% had hemicrania continua, and 27% had primary 
stabbing headache (Levy et al 2005 17). 
   Patients with prolactinomas and growth hormone-secreting 
tumours are reported to have more severe headaches than patients with 
non secreting tumours (Levy et al 2004b 17).    
   Paroxysmal and positional headaches. Harris described severe 
paroxysmal headache relieved by changes in head position as the classic 
presentation of a colloid cyst (Harris 1944). These benign tumours are of 
interest, as they may present with headache not associated with other 
symptoms and be unrecognized. Patients still die from colloid cysts when 
they present with catastrophic acute deterioration due to blockage of the 
foramen of Munroe by the pedunculated tumour. In a study of 78 
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symptomatic patients with newly diagnosed colloid cysts, 25 patients 
(32%) presented with acute deterioration, and 5 of these died. Four 
additional patients presented with sudden unexplained death caused by a 
colloid cyst for an overall mortality of 12% (de Witt Hamer et al 2002 38). 
In a study of 105 cases of colloid cysts, the classic description of the 
associated headache was uncommon, as 92% of patients reported 
generalized, intermittent headache, and only 2 patients had a postural 
component (Desai et al 2002). Papilledema was found in 76% of patients, 
and ataxia, decreased vision, and urinary incontinence were present in 
18% to 27%. 
   Pituitary apoplexy caused by infarction or hemorrhage into a 
pituitary tumour presents with acute onset of intense headache associated 
with visual loss plus or minus ocular palsies, facial numbness, or 
somnolence and pituitary insufficiency (Biousse et al 2001 39 ; Elsasser 
Imboden et al 2005 40). Four of 42 patients (9.5%) with asymptomatic, 
nonfunctioning, pituitary adenomas developed apoplexy over a 5-year 
observation period . 
   Tumour cysts may rupture, spilling their contents into the 
cerebrospinal fluid. Craniopharyngioma, dermoid, and epidermoid cyst 
ruptures have all been reported to cause headache due to the 
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inflammatory meningeal reaction caused by the irritating cyst contents 41 
The inflammation may be severe enough to cause death. 
Forsyth and Posner et al 1993  had mentioned that Headaches were 
present in 48%, equally for primary and metastatic brain tumours. Unlike 
true tension-type headaches, brain tumour headaches were worse with 
bending over in 32%, and nausea or vomiting was present in 40% of 
patients. The “classic” early morning brain tumour headache is 
uncommon. The  phenotypes of brain tumour headache is inconsistent. In 
a series of 111 patients with primary and metastatic brain tumours, 53 had 
headache attributed to the brain tumour . The headache related to brain 
tumour was described as similar to tension-type headache in 41 patients 
(77 percent), similar to migraine (although with atypical features) in five 
patients (9 percent), and was unclassifiable in seven patients (13 percent).  
Pfund et al 1999 11 had mentioned that 69% had headache and 31 
% did not have headache. In the headache group the most frequent 
findings were metastatic brain tumours and different astrocytomas. 
Hypophysis adenomas and glioblastoma multiforme were frequent in the 
no-headache group. 
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Schankin et al 20079 in his prospective study of 85 patients with 
brain tumour-associated headache found that tension-type headache 
criteria were met in nearly 40 percent .  
Valentinis et al 2010 13 in his prospective study of  98 patients with 
tumour associated headache noted that it was not possible to classify the 
headache phenotype as a primary headache syndrome for more than one-
half of the cases. In those that could be classified, the most common 
syndromes were episodic tension-type headache and episodic migraine 
without aura. 
A new or changed headache experienced by a patient with a known 
systemic malignancy should be investigated. One study reported 
intracranial metastases in 32.4% of 68 patients (Christiaans et al 2002) 13. 
Emesis, headache duration of less than 10 weeks, and non-tension-type 
headache pain were independent predictors of metastases but had low 
specificity (Christiaans et al 2002) 13. Argyriou  et al 24 reported on 54 
patients with new or changed headache, 54% of whom had intracranial 
metastases. In their series, emesis, bilateral frontotemporal headache, 
pulsating quality, moderate-to-severe intensity, duration of 8 weeks or 
longer, gait instability, and extensor plantar responses were independent 
predictors of brain metastases. 
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MATERIALS AND METHODS 
Objective 
This study is aimed to analyse the clinical profile of secondary 
headache in patients with brain tumour. 
Materials and methods 
An observational study to analyse the headache pattern in patients 
diagnosed to have brain tumour. 
Sample size : Patients in outpatient and inpatient  of  Neuro medicine and 
Neurosurgery Departments from August 2010 to December 2011. 
Study population: Patients diagnosed to have primary or secondary brain 
tumour by neuroimaging. 
Exclusion criteria:  Secondary headache due to Infections (eg, 
granulomas, abscess, encephalitis, meningitis, subdural empyema), 
Hemorrhage (intracerebral, subdural, subarachnoid), Arterial and venous 
thrombosis, chiari malformations, extracranial  and systemic causes. 
Place: Govt Stanley Medical college Hospital. 
All patients were interviewed about  their personal details 
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Any history of preexisting headache, if change in pattern and 
quality of headache, 
Current headache whether present or absent, if present, 
How long was the duration of the headache ,  
Frequency – continuous,  daily, >15/month,  thrice weekly, twice 
weekly, once weekly, less than weekly), location (which side and whether 
frontal, temporal, parietal, ocipital, hemispheric Frontoparietal,  to start 
with and  during progression whether it becomes bilateral  generalilsed 
during the episode or does it remain strictly unilateral), intensity [on a 
nominal analogue scale (NAS) from 1 to 10 with 1 for little and 10 for 
worst pain], quality of pain (dull, stinging, pulsating, tightening or band 
like, other), duration of the event (<1 h, 1–4 h, 4 h-24 h,24 hrs to 3 days, 
3–7 days, >7 days, no data), associated phenomenon during the episode-
Nausea and vomiting. Photophobia,  phonophobia, lacrimation, 
Any worsening with coughing, exercise , bending down, Any early 
morning worse headache with awakening, Any features of raised 
intracranial pressure, Any focal neurological findings associated  since 
the onset of headache, Any seizures associated  since the onset of 
headache, Whether requiring medications for relieving headache. 
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The nature of the neoplasm was obtained  
(1)By Neuro imaging with regard to  
Tumour size -Tumour size was defined as  the product of the two 
largest dimensions (in cm) and was used as a measure to differentiate 
small (<10 cm2), medium (10–20 cm2) and large tumours(>20 cm2). 
Multifocal tumours were assigned to a special category. The surrounding 
oedema was estimated subjectively on a scale of 0–3, from no oedema (0) 
to extensive oedema (3). The main location of the tumour was chosen 
from the following list: frontal, temporal, parietal, occipital, hemispheric-
frontoparietal, temporoparietal  or infratentorial, sellar ventricular. 
(2)By histopathology Statistical analysis was done using  Statistical 
analysis was performed using SPSS package 15. 
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RESULTS 
208 patients with brain neoplasm either primary or secondary were  
analysed. The results are as follows 
 Frequency Percent 
Male 109 52.4 
Female 99 47.6 
Total 208 100.0 
 
The study population consisted of 52.4%, males and 47.6% 
females whose age ranged between 13 years to 85 years with mean  
age 40.99. 
 HA present Percent HA absent Percent 
Male 98 47.11 11 5.29 
Female 
86 46.35 
13 
 
6.25 
 
Total  88.46  11.54 
 
Among  this  patients having brain neoplasm , 88.5 % ( 47.11% 
males and 46.35% females)  had headache since the beginning or during 
the course of illness.  11.5 % ( 5.29% males and 6.25% females) did not 
have headache during the course of illness till  the time of interview. 
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Location of the tumour: 
 
Location Frequency Percent 
Frontal 45 21.6 
Frontoparietal 13 6.3 
Parietal 46 22.1 
Temporal 12 5.8 
Occipital 3 1.4 
Cp angle 50 24.0 
Ventricular 17 8.2 
Sellar 12 5.8 
Multiple 2 1.0 
Thalamic 3 1.4 
Pineal 5 2.4 
Total 208 100.0 
 
The location of tumours were Frontal (21.6%), paritetal(22.1%), 
temporal(5.1%), Occipital( 1.4%), CP angle( 25%), Ventriclular( 8.2%), 
Sellar(  5.8% ), Thalamic ( 1.4%), Pineal( 2.4%), Multiple( 1%).71.2% 
were in the supratentorial compartment and 28.8 were in the infratentorial 
compartment. 
 
Location Frequency Percent 
ST 148 71.2 
IT 60 28.8 
Total 208 100.0 
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Type of tumour 
Of these,  27.9 % were gliomas (including  glioblastomas, 
astrocytomas, oligo dendrogliomas) , 26.4% were meningiomas, 3.4 % 
were pitutary macroadenomas, 0.5 craniopharyngiomas, 13.5% 
schwanomas more commonly in  cer ebelloppontine angle, 3.8% were 
ependymomas, 9% were cyst (epidermoid, arachnoid and colloid 
cyst),3.4% were cerebellar haemangioblastomas, 1.9% were cavernomas, 
4.8% were space occupying lesions unclassified (biopsy not done), and 
5.3% were secondary metastatic from elsewhere in the body. 
Headache present  and absent group: 
 
Type of tumour 
in HA present group 
No. % 
 
Type of tumour 
in HA absent group 
No. % 
Glioma 57 30.9 Glioma 1 4.2
Meningioma 55 29.8 Meningioma 0 0
Macroadenoma 
5 2.7
Pitutary 
Macroadenoma 3 12.5
Schwanoma 15 8.1 Schwanoma 13 54.2
Ependymoma 8 4.3 Ependymoma 0 0
Cyst( epidermoid, 
araachnoid, colloid 
cyst) 17 9.2
Cyst( epidermoid, 
araachnoid, colloid 
cyst) 
2 8.3
SOL unclassified 9 4.8 SOL unclassified 1 4.2
Secondary 8 4.3 Secondary 3 12.5
Heamangioblastoma 7 3.8 Heamangioblastoma 0 0
Cavernoma 3 1.6 Cavernoma 1 4.2
Total 184 100.0 Total 24 100.0
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Gliomas ( 30.9%)and meningiomas( 29.8%) were common in the 
headache group. In the headache absent group , 54.2 % were CP angle 
vestibular  schwanoms, 12.5% each were pitutary adenomas and  
secondary metastatic tumours, 4.2 % each were of glioma and 
cavernoma. 
Prexisting 
headache Frequency Percent 
Family 
history Frequency Percent
Yes 8 3.8 Yes 2 1.0
No 200 96.2 No 206 99.0
Total 208 100.0 Total 208 100.0
Prexisting headache and family history: Only 1% had  positive family history.
  
Changed 
pattern 
Frequency Duration 
Onset 
location 
quality intensity 
Changed 6(75%) 7(87.5%) 1(12.5%) 7(87.5%) 2(25%)
same 2(25%) 1(12.5%) 7(87.5%) 1(12.5%) 6(75%)
Total 8 8 8 8 8
 
1 % had positive family history. 8 patients (3.8%)  had pre existing 
headache and had a change in the some form of the pattern of headache. 
The frequency of episodes increased in 6 remained same in 2, duration of 
episode was increased in 7 remained same in 1.Headache onset location 
had changed in 1, remained same in 7. All of them had noted change in 
the quality of headache recent past .The intensity increased in 2, remained 
same in 6. 
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Duration of Headache 
Duration of 
headache Frequency Percent Valid Percent 
0 24 11.5
1 11 5.3 5.9
2 27 13.0 14.7
3 44 21.2 23.9
4 41 19.7 22.2
5 30 14.4 16.3
6 28 13.5 15.2
7 3 1.4 1.6
Total 208 100.0 100.0
 
The overall duration ranged between 1 month to 7 months. Most 
had duration around 3-4 months. 
Pattern of Headache: 
Almost all of 184 patients had a intermittent pattern of headache. 
Frequency of  Episodes of Headache: 
Frequency  Frequency Percent Valid Percent 
4 1 .5 .5
8 28 13.5 15.2
10 1 .5 .5
12 98 47.1 53.3
16 28 13.5 15.2
20 1 .5 .5
30 27 13.0 14.7
Total 184 88.5 100.0
No HA 24 11.5  
 208 100.0  
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 In general, 15.2% had 8 episodes per month. 53.3% had frequency 
of 12 per month (3 episodes per week).15.2% had 16 per month ( 4 days 
per week). 14.7% had daily headache. 
Duration of Episode: 
Duration ( in hrs) Frequency Percent Valid Percent 
Upto 4 1 .5 .5
5-24 156 75.0 84.8
Above 24 27 13.0 14.7
Total 184 88.5 100.0
No HA 24 11.5  
 208 100.0  
Most of the patients, 84.8% had headache duration ranging 
between 5- 24 hours.0.5% had headache duration less than 4 hours.  
14.7 % had headache duration more than 24 hours. 
Location of headache during onset: 
 Frequency Percent Valid Percent Cumulative Percent 
Left 95 45.7 51.6 51.6
Bilateral 39 18.8 21.2 72.8
Right 50 24.0 27.2 100.0
Total 184 88.5 100.0  
No HA 24 11.5    
 208 100.0    
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Location Frequency Percent Valid Percent 
Frontoparietal 138 66.3 75.0 
Occipital 46 22.1 25.0 
Total 184 88.5 100.0 
No HA 24 11.5   
 208 100.0   
 
During onset, Headaches were localized to  frontoparietal  of the 
side of tumour in supratentorial tumours, and bifronto parietal  in sellar 
tumours and in hydrocephalus  cases, bi occipital in  infratentorial 
tumours. Regarding side of onset 51.6% had onset in left side ipsilateral 
to the tumour, 27.2 % had to right side ipsilateral to the tumour, 21.2 % 
had bilateral headaches 
Progression of headache: 
 
Progression Frequency Percent Valid Percent 
Generalised 179 86.1 97.3 
Unilateral 5 2.4 2.7 
Total 184 88.5 100.0 
No HA 24 11.5   
 208 100.0   
 
97.3 % had progressed within half to one hour to become 
generalized. 2.7%  had remained unilateral during the entire episode. 
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Quality of headache: 
Quality Frequency Percent Valid Percent 
Dull aching 179 86.1 97.3 
Bandlike 5 2.4 2.7 
Total 184 88.5 100.0 
No HA 24 11.5   
 208 100.0   
 
97.3% reported that the headache was of dull aching   quality and 
2.7% had reported of having bandlike sensation over the head. 
Intensity of headache: 
Intensity Frequency Percent Valid Percent 
3 4 1.9 2.2 
4 13 6.3 7.1 
5 39 18.8 21.2 
6 91 43.8 49.5 
7 35 16.8 19.0 
8 2 1.0 1.1 
Total 184 88.5 100.0 
No HA 24 11.5   
 208 100.0   
 
49.5% had  Nominal analouge scaling intensity of 6. 21.2% had 
intensity of  5 and 19% had intensity scaling of 7. Only 1 % had intensity 
scaling of 8.  7.1% had intensity scaling of 4 and 1.9 % had intensity 
scaling of 3. 
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Associated Nausea  and vomiting 
Associated 
vomitting Frequency Percent Valid Percent 
Yes 57 27.4 31.0 
No 127 61.1 69.0 
Total 184 88.5 100.0 
NO HA 24 11.5   
 208 100.0   
 
In 31 % of the patient headache was associated with nausea and 
vomiting. 69% did not have associated vomiting. 
Associated photophobia, phonophobia, lacrimation 
None of the patients 184 patients had  photophobia, phonophobia  
lacrimation associated with the headache. 
Associated with worsening during cough: 
Associated 
cough Frequency Percent Valid Percent 
Yes 79 38.0 42.9 
No 105 50.5 57.1 
Total 184 88.5 100.0 
No HA 24 11.5   
 208 100.0   
 
42.9% of patients reported that they had headache worsening 
during coughing. 
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Associated with early morning headache: 
Associated early 
more HA 
Frequency Percent
Valid 
Percent 
Cumulative 
Percent 
Yes 19 9.1 10.3 10.3
No 165 79.3 89.7 100.0
Total 184 88.5 100.0  
No HA 24 11.5    
 208 100.0    
 
 Only 10.3 % had early morning headache while awakening  
from sleep. 
Asssociated worsening during exercise , bending   down: 
Bending down Frequency Percent Valid Percent
None 154 74.0 83.7 
Bending 30 14.4 16.3 
Total 184 88.5 100.0 
No HA 24 11.5   
 208 100.0   
 
Strain, exercise Frequency Percent Valid Percent 
Yes 22 10.6 12.0 
No 162 77.9 88.0 
Total 184 88.5 100.0 
No HA 24 11.5   
 208 100.0   
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12% had worsening of headache during  exercise  and 16.3 % had 
worsening of headache during bending down. 
ICT features: 
 
ICT in 
HA group 
Freq. % Valid Percent 
  
ICT in 
No HA 
group 
Freq. % Valid Percent
Yes 89 42.8 48.3  Yes 0 0 0 
No 65 35.3 51.7  No 24 24 100 
No HA 24 11.5   Total 24 100.0  
Total 208 100.0       
 
42.8 % had features of raised intra cranial tension. All the patients 
in the Headache absent group with tumour  did not have ICT. 
Associated Focal neurological deficits: 
Associated 
FND 
Freq. % 
 
Valid 
percent in 
HA 
present 
Associated
FND 
percent in 
HA 
present 
percent in 
HA absent 
Yes 80 38.5 40.76 Yes 75(93.8%) 5(6.3%)
No 128 61.5 No 127(99.2) 1(0.8)
Total 208 100.0  
 
About 38.5% had FND. In that 40.76 % had  headches associated  
with focal neurological signs like hemiparesis, hemisensory impairement, 
ataxia cranial nerve palsies, memory impairement, behavior and 
personality change, etc. 
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Seizures: 
Associated 
Seizure 
Freq. % 
 
Valid 
percent in 
HA 
present 
Seozire percent in HA present 
percent in 
HA absent 
Yes 43 20.6 23.3 Yes 42(97.7%) 1(2.3%)
No 165 79.4 No 160(97%) 5(3%)
Total 208   
 
20.6 % of 208 patients had seizure. In that 23.3% had headaches 
associated with  seizures ( focal, focal with generalization, generalized) . 
Isolated headache: 
 
Isolated headache as the symptom was observed in 30 % of the 
patients having headache. 
Haeadache relieving medication requirement: 
All patients(100%) required headache relieving medication in the 
form of  analagesics or in  some patients steroids for  reducing tumour 
associated edema. 
Isolated headache Frequency 
Valid 
Percent 
Yes 33 17.95 
Total 184  
No HA 24  
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Tumour size: 
Tumour size Frequency Percent 
Small 146 70.2 
Medium 59 28.4 
Large 3 1.4 
Total 208 100.0 
 
             Regarding  tumour  size  it was 70.2%  small  in size (<10 cm2).  
28.4% were of medium size(10-20 cm2), 1.4 % had of  large size  
(>20 cm2). 
Tumour associated edema: 
Tumour associated 
edema 
Frequency Percent 
Nil 127 61.1 
Mild 25 12.0 
Moderate 47 22.6 
Severe 9 4.3 
Total 208 100.0 
 
There was no edema in 61.1% of cases. 12% had mild edema, 
22.6% had moderate edema, 4.3% had severe edema. 
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Location of headache during onset to side of the tumour: 
Chi-Square Tests 
 
Side of 
Headache  Value df 
Asymp. Sig. 
(2-sided) 
Left Pearson Chi-Square 80.412(a) 18 .000
  Likelihood Ratio 35.196 18 .009
  Linear-by-Linear 
Association 12.094 1 .001
  N of Valid Cases 95    
Bilateral Pearson Chi-Square 46.312(b) 10 .000
  Likelihood Ratio 52.200 10 .000
  Linear-by-Linear 
Association .026 1 .871
  N of Valid Cases 39    
Right Pearson Chi-Square 6.055(c) 6 .417
  Likelihood Ratio 4.814 6 .568
  Linear-by-Linear 
Association .077 1 .782
  N of Valid Cases 50    
 
In patients with  tumours in the supratentorial  hemispheric region 
in frontal, parietal , temporal or occipital lobe, the headache was initially 
localized to the tumour side during  onset and later became  generalized. 
In midline tumourslike pitutaty tumours  headche was bi frontoparietal. In 
ventricular tumours  and in other infra temporal tumours with associated 
hydrocephalus and ICT it was bi frontoparietal during onset. In 
infratentorial tumours it was in occipital region during onset. 
 
44 
 
Duration of tumour with respect to location: 
Duration of 
headache Supratentorial Infratentorial 
0  
1 5.4% 5.0% 
2 12.2% 15.0% 
3 23.0% 16.7% 
4 20.9% 16.7% 
5 15.5% 11.7% 
6 15.5% 8.3% 
7 1.4% 1.7% 
Total 100% 100.0% 
 
More supratentorial tumours had headache of relatively  longer 
duration than infratentorial loacation. This association is stasitically 
significant ( p value 0.018) 
Intracranial tension with the location of the tumour: 
ICT    ST/IT Total P value 
   ST IT   0.398 
Yes Count 62 27 89 
  % within ICT  69.7% 30.3% 100.0% 
  % within ST/IT 41.9% 45.0% 42.8% 
No Count 86 33 119 
  % within ICT  72.3% 27.7% 100.0% 
  % within ST/IT 58.1% 55.0% 57.2% 
Total Count 148 60 208 
 % within ICT  71.2% 28.8% 100.0% 
 % within ST/IT 100.0% 100.0% 100.0% 
 
Among patients with ICT  41.9 % were of supratentorial and 45% 
were of infratentorial implying more of infratentorial tumours present 
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with raised ICP group. This association was not statistically significant  
(p value 0.4). 
Type of tumour and intensity of headache: 
   intensity Total 
   3 4 5 6 7 8   
Glioma Count 0 1 4 30 21 1 57
  % within Type  .0% 1.8% 7.0% 52.6% 36.8% 1.8% 100.0%
  % within Intt.  .0% 7.7% 10.3% 33.0% 60.0% 50.0% 31.0%
Meningioma Count 1 3 21 25 5 0 55
  % within Type  1.8% 5.5% 38.2% 45.5% 9.1% .0% 100.0%
  % within Intt.  25.0
% 23.1% 53.8% 27.5% 14.3% .0% 29.9%
Macroadenoma Count 0 0 0 5 0 0 5
  % within Type  .0% .0% .0% 100.0% .0% .0% 100.0%
  % within Intt.  .0% .0% .0% 5.5% .0% .0% 2.7%
Schwanoma Count 1 5 8 1 0 0 15
  % within Type  6.7% 33.3% 53.3% 6.7% .0% .0% 100.0%
  % within Intt.  25.0
% 38.5% 20.5% 1.1% .0% .0% 8.2%
Ependymoma Count 0 0 1 4 2 1 8
  % within Type  .0% .0% 12.5% 50.0% 25.0% 12.5% 100.0%
  % within Intt.  .0% .0% 2.6% 4.4% 5.7% 50.0% 4.3%
Cyst Count 1 2 3 8 3 0 17
  % within Type  5.9% 11.8% 17.6% 47.1% 17.6% .0% 100.0%
  % within Intt.  25.0
% 15.4% 7.7% 8.8% 8.6% .0% 9.2%
SOL 
unclassified 
Count 0 0 2 6 1 0 9
  % within Type  .0% .0% 22.2% 66.7% 11.1% .0% 100.0%
  % within Intt.  .0% .0% 5.1% 6.6% 2.9% .0% 4.9%
Secondary Count 0 0 0 6 2 0 8
  % within Type  .0% .0% .0% 75.0% 25.0% .0% 100.0%
  % within Intt.  .0% .0% .0% 6.6% 5.7% .0% 4.3%
Heamangioblast
oma 
Count 0 0 0 6 1 0 7
  % within Type  .0% .0% .0% 85.7% 14.3% .0% 100.0%
  % within Intt.  .0% .0% .0% 6.6% 2.9% .0% 3.8%
Cavernoma Count 1 2 0 0 0 0 3
  % within Type  33.3
% 66.7% .0% .0% .0% .0% 100.0%
  % within Intt.  25.0
% 15.4% .0% .0% .0% .0% 1.6%
Total Total 4 13 39 91 35 2 184
    2.2% 7.1% 21.2% 49.5% 19.0% 1.1% 100.0%
    100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
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The more intense headaches are seen with  gliomas, meningioma, 
and ventricular tumours that has caused raised  intracranial pressure.  The 
 corelation is statistically significant ( p value 0.000). 
Size of the tumour and intensity: 
Size   3 4 5 6 7 8   
 Count 4 11 22 70 16 0 123
Small % within Size 3.3% 8.9% 17.9% 56.9% 13.0% .0% 100.0%
  % within intensit 100.0% 84.6% 56.4% 76.9% 45.7% .0% 66.8%
  Count 0 2 16 21 18 1 58
Medium % within Size .0% 3.4% 27.6% 36.2% 31.0% 1.7% 100.0%
  % within intensit .0% 15.4% 41.0% 23.1% 51.4% 50.0% 31.5%
  Count 0 0 1 0 1 1 3
Large % within Size .0% .0% 33.3% .0% 33.3% 33.3% 100.0%
 % within intensit .0% .0% 2.6% .0% 2.9% 50.0% 1.6%
 Count 4 13 39 91 35 2 184
 % within Size 2.2% 7.1% 21.2% 49.5% 19.0% 1.1% 100.0%
 % within intensit 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
 
More of medium and Large size tumours have produced more  
intense headache. Small tumours have produced milder forms of 
headache. But small sized tumours have also produced more intense 
headaches .The intensity of the headache association with the size of the 
tumour is significant (p=0.000). 
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Edema and intensity: 
   intensity Total 
   3 4 5 6 7 8   
Nil Count 4 13 33 48 10 0 108
  % within Edema 3.7% 12.0% 30.6% 44.4% 9.3% .0% 100.0%
  % within intensity 100.0% 100.0% 84.6% 52.7% 28.6% .0% 58.7%
Mild Count 0 0 2 14 4 1 21
  % within Edema .0% .0% 9.5% 66.7% 19.0% 4.8% 100.0%
  % within intensity .0% .0% 5.1% 15.4% 11.4% 50.0% 11.4%
Moderate Count 0 0 4 28 14 1 47
  % within Edema .0% .0% 8.5% 59.6% 29.8% 2.1% 100.0%
  % within intensity .0% .0% 10.3% 30.8% 40.0% 50.0% 25.5%
Severe Count 0 0 0 1 7 0 8
 % within Edema .0% .0% .0% 12.5% 87.5% .0% 100.0%
 % within intensity .0% .0% .0% 1.1% 20.0% .0% 4.3%
 Count 4 13 39 91 35 2 184
 % within Edema 2.2% 7.1% 21.2% 49.5% 19.0% 1.1% 100.0%
 % within intensity 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
 
90 % of mild , 92% of moderate and  100 % of severe edema 
patients had more intense (intensity scaling of 6 and more ) headaches 
than patients with no edema ( 53%). More of no edema group(47 %)  
were associated with milder intensity headaches. But milder and no 
edema group were also associated with more intense headaches. The 
intensity of the headache correlates with the size of the tumour which is 
significant (p=0.000) 
Intensity and ICT: 
Intensity 
of  HA  ICT features Total 
   Yes No   
3 Count 0 4 4
 % within intensity .0% 100.0% 100.0%
 % within ICT features .0% 4.1% 2.2%
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4 Count 2 11 13
 % within intensity 15.4% 84.6% 100.0%
 % within ICT features 2.3% 11.3% 7.1%
5 Count 9 30 39
 % within intensit 23.1% 76.9% 100.0%
 % within ICT features 10.3% 30.9% 21.2%
6 Count 45 46 91
 % within intensity 49.5% 50.5% 100.0%
 % within ICT features 51.7% 47.4% 49.5%
7 Count 29 6 35
 % within intensity 82.9% 17.1% 100.0%
 % within ICT features 33.3% 6.2% 19.0%
8 Count 2 0 2
 % within intensity 100.0% .0% 100.0%
  % within ICT features 2.3% .0% 1.1%
 Count 87 97 184
 % within intensity 47.3% 52.7% 100.0%
 % within ICT features 100.0% 100.0% 100.0%
  
More percentage of patients in the raised ICP group (87.3%) had 
more intensity headaches( intensity scaling of 6 and more) than patients 
in the normal ICP group (53.6).  
Type of tumour and ICT 
   
  
ICT features Total 
  
Yes No 
Glioma Count 45 13 58
  % within Nature of 
tumour 77.6% 22.4% 100.0%
  % within ICT features 50.6% 10.9% 27.9%
Meningioma Count 11 44 55
  % within Nature of 
tumour 20.0% 80.0% 100.0%
  % within ICT features 12.4% 37.0% 26.4%
Macroadenoma Count 0 8 8
  % within Nature of .0% 100.0% 100.0%
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tumour 
  % within ICT features .0% 6.7% 3.8%
Schwanoma Count 3 25 28
  % within Nature of 
tumour 10.7% 89.3% 100.0%
  % within ICT features 3.4% 21.0% 13.5%
Ependymoma Count 7 1 8
  % within Nature of 
tumour 87.5% 12.5% 100.0%
  % within ICT features 7.9% .8% 3.8%
Cyst Count 11 8 19
  % within Nature of 
tumour 57.9% 42.1% 100.0%
  % within ICT features 12.4% 6.7% 9.1%
SOL Count 3 7 10
  % within Nature of 
tumour 30.0% 70.0% 100.0%
  % within ICT features 3.4% 5.9% 4.8%
Secondary Count 2 9 11
  % within Nature of 
tumour 18.2% 81.8% 100.0%
  % within ICT features 2.2% 7.6% 5.3%
Heamangioblas
toma 
Count 7 0 7
  % within Nature of 
tumour 100.0% .0% 100.0%
  % within ICT features 7.9% .0% 3.4%
Cavernoma Count 0 4 4
  % within Nature of 
tumour .0% 100.0% 100.0%
  % within ICT features .0% 3.4% 1.9%
 Count 89 119 208
 % within Nature of 
tumour 42.8% 57.2% 100.0%
 % within ICT features 100.0% 100.0% 100.0%
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ICT is more commonly seen with glioma( 50.6)%, ventricular 
tumours like ependymomas, colloid cyst of ventricles(20.3%). These 
associations are significant ( p value = 0.000). 
Size of the tumour in in Sq cm and  Tumour edema and Headache 
intensity : 
  
intensity   
  
Edema 
Total   Nil Mild Moderate Severe 
3 Size in 
Sq cm 
Small Count 4      4
  % within Size in Sq 
cm 100.0%      100.0%
% within Edema 100.0%      100.0%
Total Count 4      4
  % within Size in Sq 
cm 100.0%      100.0%
% within Edema 100.0%      100.0%
4 Size in 
Sq cm 
Small Count 11      11
    % within Size in Sq 
cm 100.0%      100.0%
% within Edema 84.6%      84.6%
Medium Count 2      2
% within Size in Sq 
cm 100.0%      100.0%
% within Edema 15.4%      15.4%
Total Count 13      13
  % within Size in Sq 
cm 100.0%      100.0%
% within Edema 100.0%      100.0%
5 Size in 
Sq cm 
Small Count 19 2 1   22
    % within Size in Sq 
cm 86.4% 9.1% 4.5%   100.0%
% within Edema 57.6% 100.0% 25.0%   56.4%
Medium Count 13 0 3   16
% within Size in Sq 
cm 81.3% .0% 18.8%   100.0%
% within Edema 39.4% .0% 75.0%   41.0%
Large Count 1 0 0   1
% within Size in Sq 
cm 100.0% .0% .0%   100.0%
% within Edema 3.0% .0% .0%   2.6%
Total Count 33 2 4   39
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  % within Size in Sq 
cm 84.6% 5.1% 10.3%   100.0%
% within Edema 100.0% 100.0% 100.0%   100.0%
6 Size in 
Sq cm 
Small Count 39 11 19 1 70
  % within Size in Sq 
cm 55.7% 15.7% 27.1% 1.4% 100.0%
% within Edema 81.3% 78.6% 67.9% 100.0% 76.9%
Medium Count 9 3 9 0 21
% within Size in Sq 
cm 42.9% 14.3% 42.9% .0% 100.0%
% within Edema 18.8% 21.4% 32.1% .0% 23.1%
Total Count 48 14 28 1 91
  % within Size in Sq 
cm 52.7% 15.4% 30.8% 1.1% 100.0%
% within Edema 100.0% 100.0% 100.0% 100.0% 100.0%
7 Size in 
Sq cm 
Small Count 4 2 7 3 16
    % within Size in Sq 
cm 25.0% 12.5% 43.8% 18.8% 100.0%
% within Edema 40.0% 50.0% 50.0% 42.9% 45.7%
Medium Count 5 2 7 4 18
% within Size in Sq 
cm 27.8% 11.1% 38.9% 22.2% 100.0%
% within Edema 50.0% 50.0% 50.0% 57.1% 51.4%
Large Count 1 0 0 0 1
% within Size in Sq 
cm 100.0% .0% .0% .0% 100.0%
% within Edema 10.0% .0% .0% .0% 2.9%
Total Count 10 4 14 7 35
  % within Size in Sq 
cm 28.6% 11.4% 40.0% 20.0% 100.0%
% within Edema 100.0% 100.0% 100.0% 100.0% 100.0%
8 Size in 
Sq cm 
Medium Count  0 1   1
  % within Size in Sq 
cm  .0% 100.0%   100.0%
% within Edema  .0% 100.0%   50.0%
Large Count  1 0   1
% within Size in Sq 
cm  100.0% .0%   100.0%
% within Edema  100.0% .0%   50.0%
Total Count  1 1   2
  % within Size in Sq 
cm  50.0% 50.0%   100.0%
% within Edema  100.0% 100.0%   100.0%
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Correlations 
 
    size   Edema intensity 
Size  Pearson 
Correlation 1 .098 .194(**) 
Sig. (2-tailed) . .158 .008 
N 208 208 184 
Edema Pearson 
Correlation .098 1 .460(**) 
Sig. (2-tailed) .158 . .000 
N 208 208 184 
intensit Pearson 
Correlation .194(**) .460(**) 1 
Sig. (2-tailed) .008 .000 . 
N 184 184 184 
**  Correlation is significant at the 0.01 level (2-tailed). 
 
This  shows that even smaller sized tumours with edema have more 
intense headache than large tumours without edema. These associations 
are significant (p value 0.01). 
Relation between Size of the tumour, its edema and the frequency of 
episodes: 
Frequency 
of 
episodes 
( per 
month) 
 
 
Edema 
Total 
  Nil Mild Moderate Severe 
Upto 4 Size in 
Sq cm 
Medium Count 1      1
  % within Size in 
Sq cm 100.0%      100.0%
% within Edema 100.0%      100.0%
Total Count 1      1
  % within Size in 
Sq cm 100.0%      100.0%
% within Edema 100.0%      100.0%
5-24 Size in 
Sq cm 
Small Count 75 12 19 2 108
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    % within Size in 
Sq cm 69.4% 11.1% 17.6% 1.9% 100.0%
% within Edema 71.4% 70.6% 61.3% 66.7% 69.2%
Medium Count 28 4 12 1 45
% within Size in 
Sq cm 62.2% 8.9% 26.7% 2.2% 100.0%
% within Edema 26.7% 23.5% 38.7% 33.3% 28.8%
Large Count 2 1 0 0 3
% within Size in 
Sq cm 66.7% 33.3% .0% .0% 100.0%
% within Edema 1.9% 5.9% .0% .0% 1.9%
Total Count 105 17 31 3 156
  % within Size in 
Sq cm 67.3% 10.9% 19.9% 1.9% 100.0%
% within Edema 100.0% 100.0% 100.0% 100.0% 100.0%
Above 24 Size in 
Sq cm 
Small Count 2 3 8 2 15
  % within Size in 
Sq cm 13.3% 20.0% 53.3% 13.3% 100.0%
% within Edema 100.0% 75.0% 50.0% 40.0% 55.6%
Medium Count 0 1 8 3 12
% within Size in 
Sq cm .0% 8.3% 66.7% 25.0% 100.0%
% within Edema .0% 25.0% 50.0% 60.0% 44.4%
Total Count 2 4 16 5 27
  % within Size in 
Sq cm 7.4% 14.8% 59.3% 18.5% 100.0%
% within Edema 100.0% 100.0% 100.0% 100.0% 100.0%
 
Correlations: 
   Size  Edema Frequency
Size Pearson 
Correlation 1 .098 .057
  Sig. (2-tailed) . .158 .441
  N 208 208 184
Edema Pearson 
Correlation .098 1 .582(**)
  Sig. (2-tailed) .158 . .000
  N 208 208 184
Frequency Pearson 
Correlation .057 .582(**) 1
  Sig. (2-tailed) .441 .000 .
  N 184 184 184
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With respect  to frequency of the episodes per month,  the extent of 
edema plays a significant role. This relationship is statistically significant 
p value (0.000). 
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DISCUSSION 
The age of the study population of 208 patients consisting of  
52.4% male and 47.6%  female patients ranged between 13 years to 85 
years. The median age was 41. All the patients in the study population 
could not be complied with the ICHD-II 7.4 definition of Headache 
attributable to intracranial neoplasms. Hence, this study is an analysis of 
the pattern of headache prevailing in patients with brain tumours . The 
study has a limitation that it was carried out in the patients attending 
neuro department of a small referral centre . 
The prevalence of headache in the present study was  88.5%.  
(47.11% males and 46.35% females).They had headache since the 
beginning or during the course of illness. 11.5 %  ( 5.29% males and 
6.25% females) did not have headache during the course of illness till  the 
time of interview. But previous studies have shown 48%( Forsyth  
and Posner 1993 12), 58.8% ( Pfund et al 1999 11), 60% ( Schankin et al 
20079), 47.6% (Valentinis et al 2010 13). 
Regarding the type of tumours, gliomas( 30.9%) and meningiomas 
(29.8%)  were the  most common in the headache group. In the headache 
absent group of patients, vestibular schwanomas (54.2%) were most 
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commonly seen in this study. But pfund et al 11 in their study had stated 
that in the headache group the most frequent findings were metastatic 
brain tumors and different astrocytomas. Hypophysis adenomas and 
glioblastoma multiforme were frequent in the no-headache group. 
Location of headache and progression: 
Regarding location of headache, 66.3 % had onset in the fronto 
parietal and 22.1 % had occipital .  
During onset, in patients with tumours in the supratentorial  
hemispheric region in frontal, parietal , temporal or occipital lobe or 
frontoparietal or temporoparietal, headache was localized to the tumour 
side during onset and later became  generalized. In 2.7%  Headache had 
remained unilateral during the entire episode. The side of onset 51.6% 
had onset in left side ipsilateral to the tumour, 27.2 % had to right side 
ipsilateral to the tumour, 21.2 % had bilateral headaches. 
In tumours near midline like pitutary tumours, headache was bi 
frontoparietal. In ventricular tumours  and in other infra temporal tumours 
with associated hydrocephalus and raised intracranial pressure, it was bi 
frontoparietal during onset. In infratentorial tumours it was in occipital 
region during onset. These are due to region based stimulation and 
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refered pain in the trigrminal nerve distribution  in supratentorial or 
cervical nerve distribution in infratentorial tumours. These associations 
although corresponding to the location of tumour were not significant 
statistically ( Left side  p= 0.000, bilateral p value=0.000, right side  
p value=0.417)  for all these location of onset of headache. 
These observations are consistent with previous study. Forsyth and 
Posner et al.,12 who had stated that patients with unilateral headache had 
an ipsilateral tumor. Most patients with infratentorial tumors have 
supratentorial headaches only; but if occipital pain is present, an 
infratentorial tumor is more likely (pfund et al 11). Headache has 
lateralizing value, especially in patients with supratentorial lesions who 
have no obvious increased intracranial pressure (Suwanwela et al 1994 20) 
.  Infratentorial tumours were found to be significantly more often 
associated with occipital and less often with frontal headache. If headache 
was unilateral, then headache and tumour were on the same side in only 
61.5% (Schankin et al 9 )But in contrast, other previous studies had stated 
headache lateralization predicted tumor location in only one third of 
patients (pfund et al 1999 11), Frontal headaches were the most unreliable 
in predicting tumor location and were most common ( Valentinis et al 
2010 13).  
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Pattern of headache: 
All the patients in the headache group had intermittent pattern of 
headache with varying frequency of episodes of vary,most (47.1%) of the 
patients had about 12 days a month and each episode lasting between 4-
24 hours. This is consistent with pfund et al 11  and Suwanwela  et al  20 
who has stated that the headache was never permanent and there was no 
regular daily recurrence.  
The duration of headache in recent onset headache ranged between 
1 to 7 months. More of  supratentorial tumours had headache of relatively  
longer duration than infratentorial location. This is statistically significant 
( p= 0.018). 
Quality of headache: 
 In this study 86.1 % had dull aching type of pain and 2.7 % had 
band like pain. This is consistent with Forsyth posner 12, pfund etal 11, 
Schankin et al 9 and suwanwela etal 20. 
 49.5 % had headache intensity under nominal analogue scaling of 6 
and 19 %  had scaling of 7 and 21.2 % had scaling of 5.  9.3 % had 
scaling less than 5,  suggesting that brain tumour associated headache  is 
a moderate to severe intensity type which is consistent with previous 
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studies (Forsyth and Posner 12; Pfund et al 11 ; Schankin et al 9; Valentinis 
et al  13). All the patients required analgesics for relieving their headache, 
some patients with tumour associated edema were benefitted from 
steroids. 
Associated symptoms and aggravating  associations : 
All the patients ( 100 % ) in the headache group did not have photo 
phobia or phonophobia . 31 % in the headache group had associated 
nausea and vomiting. 43 % of the patients had headache worsening with 
cough, 16.3 % had headache worsening with bending down, 12 % had 
worsening during strain, 10.3 % had early morning headache. 40.8 % had 
focal neurological signs and 23.3 % had seizures .These observations are 
consistent with previous studies  that nausea and vomiting are reported in 
18% to 60%, 20% report headache exacerbation by Valsalva maneuvers, 
about a third of patients have nocturnal or morning headaches  
or both .(Forsyth and Posner 12; Pfund et al 11; Schankin et al 9;  
Valentinis et al 13).  
 42.8 % had features of raised intra cranial tension. All the patients 
in the headache absent group with tumour did not have raised intracranial 
pressure. This suggests that intracranial pressure is one of the important 
factor in the manifestation of headache. 
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Among patients with raised  intracranial pressure, 41.9 % were of 
supratentorial and 45% were of infratentorial in location, implying that 
more of infratentorial tumours present with raised intracranial pressure. 
This association was not statistically significant (p value 0.4). Previous 
studies have stated that posterior fossa tumor causes headache more often 
than a supratentorial tumor (Purdy RA, Kirby S 14 ). 
 Isolated headache as the symptom was observed in 17.9 % of the 
patients having headache. Previous studies have mentioned that fifteen 
patients (8%) exhibited headache as their first and isolated clinical 
manifestation and posterior fossa location and hydrocephalus were more 
frequent in patients who presented with headache as the first symptom 
(Vázquez-Barquero etal 19 ) and pain was the first compliant in half of the 
patients ( pfund et al 11) .  
Type of the tumour and intensity of headache: 
More of greater intensity headaches are seen with  gliomas, 
meningioma, and tumours that have caused raised  intracranial pressure. 
The corelation is statistically significant ( p value 0.000).These are 
consistent with previous studies (Shankin et al 9). With pituitary 
macroadenomas, both small and medium sized tumours have caused  
moderate intensity headache. These observations are consistent with 
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previous studies that pituitary volume  and the presenting phenotype is 
likely to be governed by a combination of factors, including tumour 
activity, relationship to the cavernous sinus and patient predisposition to 
headache ( Levy et al 17). 
Size of the tumour and intensity of headache: 
Most of medium and large size tumours have produced more  
intense headaches when compared with the small sized tumours which 
have produced milder forms of headache. As certain small sized tumours 
have also produced more intense headaches, probably some other factors 
like edema may also be contributing to the intensity of the headache, 
suggesting that size of the tumour  is one of the factor requiring 
modification by other factors like edema, development of  raised ICP, 
vascular or meningeal involvement, etc. in determining the headache 
intensity. The intensity of the headache has association with the size of 
the tumour which is significant (p=0.000). Valentinis et al 2010 13   have 
stated that within similar pathologies, increased size was associated with 
increased risk of headache, but others studies (Pfund et al 1999 11; Levy 
et al  2004b 17; Schankin et al 2007 9;) have not shown this association. 
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Tumour associated edema and intensity of headache: 
More number of patients with mild, moderate and severe edema 
had more intense headaches than patients with no edema. More of the 
patients without edema were associated with milder intensity headaches. 
As mild and no edema group were also associated with more intense 
headaches, probably  due to other associated factors and mechanisms in 
the causation of headache. The intensity of the headache association with 
the extent of edema due to tumour is significant (p=0.000) 
Intensity and Intracranial pressure: 
Intense headaches of scaling 6  and more were seen in  with more 
number of patients with raised Intracranial pressure group than in patients 
without raised Intracranial pressure. 
Type of tumour and Intracranial pressure: 
Intracranial pressure is more commonly seen with gliomas, 
ventricular tumours like ependymomas, colloid cyst of ventricles .  These 
associations are significant ( p value = 0.000). 
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Size of the tumour in in Sq cm and  Tumour edema and Headache 
intensity: 
This  shows that even smaller sized tumours with edema have more 
intense headache than large tumours without edema illustrating that 
edema is an important factor  in determining  the intensity of the 
headache. The size of the tumour and edema are important associated 
factors in determining the intensity along with other factors. Among them 
edema is more significant .This is statistically significant (p value 0.01). 
Size of the tumour, its edema and the frequency of episodes: 
The frequency of episodes were less in the mild edema group and 
more in the severe edema group. Even large sized tumours have caused 
lesser frequency of episodes. Hence with regard to frequency of the 
episodes per month, the extent of edema plays a significant role. This 
association is statistically significant ( p value 0.000). 
Factors that predict increased risk of headache in patients with 
brain tumor include infratentorial location, raised intracranial pressure, 
degree of midline shift, and increasing edema (Forsyth and Posner  
1993 12; Pfund et al 1999 11). The relationship between tumor size and the 
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likelihood of headache is uncertain. Similar to the findings of Forsyth and 
Posner, Valentinis etal  13 found that within similar pathologies, increased 
size was associated with increased risk of headache, but others did not 
have similar findings (Pfund et al 11 ; Levy et al 17; Schankin et al 9; 
Valentinis et al 13). 
Pre-existing headache: 
All the patients with pre existing headache had increased 
frequency, duration and headache quality of episodes without much 
alteration in the intensity or location of headache. One patient (12.5%) 
continued to have the same pattern of headache .These observations were 
consistent with previous studies (Schankin et al 9). 
While attempting to classify these headache pattern under  primary 
headache types, the criteria for tension type of headache was met in  
67 patients (36.4%) and for other types in none, consistent with  
previous studies, report that  it was of tension type in 32 % and none in 
other types (schankin et al 9 , Valentinis et al 2010 13). 
In general, brain tumour headaches in contrast  to primary 
headaches are  of  more of unilateral during onset, dull aching type of 
pain, recent onset  or change in pattern with pre-existing headache, 
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progressive in nature, worsening with valsalva, change in position or 
exertion, associated with seizures or neurological signs. 
  Eventhough only a small minority of patients with headache have 
brain tumor as the cause, it is crucial to recognize those headache 
characteristics that are associated with tumors. Because of the variable 
nature of headache among patients with brain tumor, the diagnosis of 
headache attributed to brain tumor should be considered in patients who 
complain of a headache with any of the following "red flags": 
• Acute, new, usually severe headache or headache that has changed 
from previous patterns  
• New headache onset in an adult, especially over 50 years of age  
• Headache in the elderly or in children  
• Headache on exertion, onset at night, or onset at early morning  
• Headache that is progressive in nature  
• Headache associated with fever or other systemic symptoms  
• Headache with meningismus  
• Headache with new neurologic signs  
• Precipitation of head pain with the Valsalva maneuver (by 
coughing, sneezing, or bending over) 
In patients with any of the above features, further investigation 
with neuroimaging is warranted. 
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SUMMARY 
An observational study analyzing the pattern of headache in 208 
patients with brain tumor. 
The prevalence of headache was  88.5%. 
During onset, supratentorial tumours had  ipsilateral frontoparietal  
localization, pituitary tumours  and tumours causing raised intracranial 
pressure had bilateral  and infratentorial tumours  without raised ICP to 
occipital localization. All these later had become generalized. 
Recent onset headache having intermittent pattern  of mostly dull 
aching nature or occasionally band like, of moderate to severe intensity  
(70 % ). 
31% had associated vomiting, 43 % had worsening with 
coughing,16.3 % had worsening with bending down, 12 % had worsening 
during strain, 10.3 % had early morning headache. 
40.8 % had focal neurological sings and 23.3 % had seizures. 
Isolated headache as the symptom was observed in 17.9 % of the patients 
having headache. 
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3.8 % had pre existing headache, of them 87.5 % of patients had 
increased frequency, duration  and headache quality of episodes without 
much alteration in the intensity or location of headache. 
The criteria for tension type of headache was met in 67 patients 
(36.4% ) and for other types in none in these patients with secondary 
brain tumour headache. 
More greater intensity headaches were seen with gliomas, 
meningioma, and tumours that has caused raised  intracranial pressure. 
The size of the tumour  is one of the factor requiring modification 
by other factors like edema, development of  raised ICP, vascular or 
meningeal involvement, etc. in determining the headache. 
The intensity of the headache significantly correlates with the 
extent of edema due to the tumour. 
Intense headaches of scaling 6  and more were seen in  with more 
number of patients with raised Intracranial pressure group than in patients 
without raised Intracranial pressure. 
Intracranial pressure is more commonly seen with gliomas, 
ventricular tumours like ependymomas, colloid cyst of ventricles. 
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The size of the tumour has a role, requiring other modifying factors 
in causing headache. 
The extent of edema plays a significant role with regard to 
frequency of the episodes per month. 
Factors that predicting increased risk of headache in patients with 
brain tumour are  infratentorial  location , raised intracranial pressure, 
degree of midline shift, and increasing edema . 
Headache attributed to brain tumor should be considered, requiring 
neuro imaging, in patients who complain of a headache with any of the  
"red flags": 
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        CONCLUSION 
This study concludes that the clinical profile of brain tumour 
associated headaches are having the special characteristics  features of  
unilaterality , dull ache, recent onset or change in pattern with pre 
existing headache, progressive in nature, headache intensity worsening 
with valsalva, change in position or during exertion and  in association 
with seizures or neurological deficits. The extent of tumour associated 
edema, and raised intracranial pressure are significantly important factors 
in tumour associated headache. 
Based on these special characteristic features, the study states that 
even if the headache does not have all the characteristic features, presence 
of any one or more of the above mentioned features should prompt 
suspicion of intracranial space occupying lesion and should be 
investigated with neuroimaging for early diagnostic and therapeutic 
intervention. 
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The Temporal Profile of Space occupying lesion of brain
headache
Proforma
 Name: Age: sex: OP/ IP no:
 address:
History:
Headache
Duration:
Intermittent/ continuous,
Intermittent:  Frequency:                       days/ month
Episode duration:      Less than 4 hrs/ 4- 24 hrs/ more than 24 hrs
side of onset:  Right/ left/ Bilateral
Progression: whether it becomes bilateral  generalilsed or remains
unilateral
intensity (NAS scaling from 1 to 10  :
with 1 for little and 10 for worst pain]
quality of pain (dull, stinging, pulsating, tightening or band
like,others )
Associated phenomenon during the episode-
Nausea and vomiting :
Photophobia ,  phonophobia, lacrimation
Worsening with coughing, exercise , bending down
Any early morning worse headache with awakening
Any H/o  seizures associated  :
Whether requiring medications for relieving headache and nature of
medications used:
Other neurological symptoms:
Other system symptoms:
Examination:
Higher Function:
Cranial .Nerve :  Fundus:
Motor:
Sensory:
Coordination
Spine and cranium:
Investigations
Routine:
Endocrine:
Neuro Imaging details:
Location:
Probable type:
Tumour size  approximate in two dimensions( in cm2 ) :
Associated edema : (scaling of 0-3 from no oedema (0) to extensive
oedema (3))
Biopsy of the tumour:
Other investigations:.
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1 21 1 2 11 6 1 1 2 2 6 1 12 2 2 1 1 1 6 2 2 2 2 2 2 2 2 2 1 10 1 0
2 39 1 2 8 3 1 1 2 2 4 1 16 2 1 1 1 1 6 2 2 2 2 2 1 2 1 2 2 12 2 0
3 20 1 3 4 1 1 1 2 2 5 1 12 2 3 1 1 1 4 2 2 2 2 2 1 2 2 2 1 9 1 0
4 45 1 3 2 1 1 1 2 2 4 1 16 2 3 1 1 1 7 2 2 1 2 2 1 2 2 1 1 13 2 3
5 28 2 1 1 2 1 1 1 1 3 1 10 2 1 1 1 1 4 1 2 1 1 2 1 1 1 1 1 20 2 0
6 45 2 3 3 2 1 1 2 2 6 1 12 2 3 1 1 1 5 2 2 1 2 2 2 1 2 2 1 16 2 0
7 33 2 1 4 1 1 1 2 2 4 1 20 2 1 1 1 1 6 1 2 1 1 1 2 1 2 2 1 12 2 2
8 14 2 3 6 1 1 2 2 2 6 1 30 3 3 2 1 1 7 1 2 1 1 2 2 1 2 2 1 8 1 2
9 46 2 1 3 1 1 1 2 2 5 1 30 3 1 1 1 1 8 1 2 1 1 1 2 1 2 1 1 12 2 2
10 24 1 3 7 5 1 1 2 2 4 1 16 2 3 1 1 1 7 1 2 1 1 2 2 1 2 2 1 30 3 0
11 21 2 1 5 2 1 1 1 1 3 1 16 2 1 1 1 1 6 2 2 1 2 2 1 2 2 2 1 12 2 0
12 49 1 2 8 7 1 1 2 2 5 1 12 2 2 1 1 1 6 2 2 2 2 2 2 2 2 2 1 4 1 0
13 67 1 1 3 2 1 1 2 2 5 1 16 2 1 1 1 1 3 2 2 2 2 2 1 2 1 2 1 8 1 0
14 16 1 3 2 2 1 1 2 2 6 1 12 2 3 1 1 1 5 2 2 2 2 2 1 2 2 2 1 8 1 0
15 45 1 1 2 1 1 1 2 2 4 1 30 3 1 1 1 1 7 1 2 1 1 1 2 1 1 1 1 16 2 2
16 40 1 1 6 6 1 2 2 2 7 1 8 2 1 2 1 1 3 2 2 2 2 2 1 2 2 2 1 6 1 0
17 23 1 1 1 2 1 1 2 2 2 1 8 2 1 1 2 1 6 1 2 1 2 2 1 1 2 2 1 12 2 0
18 15 1 3 2 10 1 1 2 2 4 1 8 2 1 1 1 1 3 2 2 2 2 2 1 2 2 2 2 6 1 0
19 47 1 2 8 7 1 1 2 2 5 1 12 2 2 1 1 1 6 2 2 2 2 2 2 2 2 2 1 4 1 0
20 40 1 1 3 10 1 1 2 2 5 1 8 2 1 1 1 1 4 2 2 2 2 2 1 2 2 2 1 8 1 0
21 42 1 1 4 2 1 1 2 2 3 1 16 2 1 1 1 1 5 2 2 1 2 2 1 1 2 2 1 12 2 0
22 52 1 3 6 4 1 2 2 2 2 1 8 2 3 2 1 1 3 2 2 2 2 2 1 2 1 2 1 6 1 0
23 50 1 3 1 1 1 1 2 2 3 1 16 2 3 1 1 1 7 1 2 1 2 2 1 1 2 1 1 8 1 2
24 50 1 3 6 4 2 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 6 1 0
25 50 1 1 1 2 1 1 2 2 4 1 12 2 1 1 1 1 4 2 2 2 2 2 1 2 2 2 1 10 1 0
26 44 1 1 6 4 2 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 8 1 0
27 58 1 3 1 2 1 1 2 2 3 1 12 2 3 1 1 1 5 2 2 2 2 2 1 2 1 2 1 9 1 0
28 59 1 1 2 2 1 1 2 2 6 1 8 2 1 1 2 1 6 2 2 1 2 2 1 2 2 2 1 8 1 0
29 28 1 1 6 6 1 2 2 2 5 1 8 2 1 2 1 1 4 2 2 2 2 2 1 2 2 2 1 6 1 0
30 16 1 1 1 1 1 1 2 2 3 1 30 3 1 1 1 1 7 1 2 1 1 2 1 1 1 1 1 8 1 3
31 42 1 2 7 5 1 1 2 2 6 1 12 2 2 1 1 1 6 2 2 2 2 2 1 1 1 2 1 2 1 0
32 46 1 1 3 8 1 1 2 2 2 1 30 3 1 1 1 1 7 2 2 1 2 1 1 2 2 1 1 8 1 1
Sl
.
N
o
.
A
g
e
S
e
x
S
i
d
e
 
o
f
 
t
u
m
o
u
r
L
o
c
a
t
i
o
n
 
o
f
 
T
u
m
o
u
r
T
y
p
e
 
o
f
 
T
u
m
o
u
r
H
e
a
d
a
c
h
e
T
e
n
t
o
r
i
a
l
 
L
o
c
a
t
i
o
n
F
a
m
 
H
/
O
 
H
A
P
r
e
e
x
i
s
t
i
n
g
 
H
A
D
u
r
a
t
i
o
n
I
n
t
e
r
m
i
t
t
e
n
t
t
/
 
C
o
n
t
i
n
u
o
u
s
F
r
e
q
u
e
n
c
y
D
u
r
a
t
i
o
o
n
 
o
f
 
e
p
i
s
o
d
e
S
i
d
e
 
o
f
 
o
n
s
e
t
 
o
f
 
H
A
L
o
c
a
t
i
o
n
 
o
f
 
H
A
G
e
n
/
U
n
i
l
a
t
e
r
a
l
 
Q
u
a
l
i
t
y
I
n
t
e
n
s
i
t
y
V
o
m
i
t
t
i
n
g
 
P
h
o
t
o
p
h
o
b
i
a
c
o
u
g
h
 
w
o
r
s
e
n
i
n
g
s
t
r
a
i
n
 
w
o
r
s
e
n
i
n
g
E
a
r
l
y
 
m
o
r
 
H
A
p
o
s
u
r
a
l
 
w
o
r
s
e
n
i
n
g
I
C
T
 
 
f
e
a
t
u
r
e
s
F
N
D
S
e
i
z
u
r
e
s
M
e
i
c
a
t
i
o
n
 
r
e
q
u
i
r
e
d
S
i
z
i
 
i
n
 
S
q
 
c
m
S
i
z
e
 
g
r
a
d
i
n
g
E
d
e
m
a
33 28 1 1 3 1 1 1 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 2 1 2 6 1 3
34 42 1 1 6 4 1 2 2 2 5 1 12 2 1 2 1 1 4 2 2 2 2 2 1 2 1 2 1 6 1 0
35 50 1 1 2 1 1 1 2 2 3 1 16 2 1 1 1 1 6 1 2 2 2 2 1 1 1 1 1 8 1 2
36 35 1 1 6 9 1 2 2 2 4 1 12 2 1 2 1 1 6 1 2 1 2 2 1 1 1 2 2 6 1 1
37 30 1 3 6 4 1 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 8 1 0
38 40 1 3 3 1 1 1 2 2 4 1 16 2 3 1 1 1 7 1 2 1 2 2 1 1 2 2 1 6 1 2
39 70 1 1 3 1 1 1 2 2 2 1 30 3 1 1 1 1 6 1 2 2 2 2 1 1 1 1 1 6 1 2
40 65 1 1 2 1 1 1 2 2 3 1 12 2 1 1 1 1 6 1 2 2 2 2 1 1 1 1 1 6 1 2
41 34 1 2 8 3 1 1 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 8 1 0
42 30 1 1 1 1 1 1 2 2 3 1 30 3 1 1 1 1 7 2 2 2 2 2 1 1 2 2 1 6 1 2
43 24 1 2 7 6 1 1 2 2 6 1 8 2 2 1 1 1 6 2 2 1 2 2 1 1 2 2 1 8 1 0
44 52 1 1 3 2 1 1 2 2 6 1 8 2 1 1 1 1 6 2 2 2 2 2 1 2 2 2 1 10 1 0
45 58 1 3 1 1 1 1 2 2 3 1 30 3 2 1 1 2 7 1 2 1 1 1 1 1 1 2 1 12 2 2
46 40 1 1 3 5 1 1 2 2 4 1 12 2 1 1 1 1 5 2 2 2 2 2 1 2 2 2 1 6 1 0
47 50 1 2 8 7 1 1 2 2 5 1 12 2 2 1 1 1 6 2 2 2 2 2 2 2 2 2 1 4 1 0
48 65 1 1 6 4 1 2 2 2 5 1 12 2 1 2 1 1 6 2 2 2 2 2 2 1 2 2 1 8 1 0
49 36 1 3 3 2 1 1 2 2 6 1 12 2 3 1 1 1 5 2 2 2 2 2 1 2 2 2 1 8 1 0
50 46 2 2 8 3 1 1 2 2 5 1 12 2 2 1 1 1 6 2 2 2 2 2 1 2 1 2 2 10 1 0
51 70 2 1 9 8 1 1 2 2 3 1 16 2 1 1 1 1 6 2 2 2 2 2 1 2 2 1 1 8 1 1
52 45 2 2 7 6 1 2 2 2 4 1 12 2 2 2 1 1 6 2 2 1 2 2 2 1 2 2 1 6 1 0
53 40 2 1 1 2 1 1 2 2 4 1 16 2 1 1 1 1 5 2 2 2 2 2 1 2 2 2 1 14 2 0
54 13 2 1 3 2 1 1 2 2 7 1 12 2 1 1 1 1 6 2 2 2 2 2 1 2 2 2 1 10 1 0
55 48 2 1 6 4 1 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 6 1 0
56 36 2 1 2 1 1 1 2 1 4 1 16 2 1 1 1 1 6 1 2 1 1 2 2 1 1 1 1 12 2 2
57 42 2 1 6 6 1 2 2 2 6 1 12 2 1 2 1 1 5 2 2 2 2 2 1 2 2 2 1 8 1 0
58 45 2 3 4 2 1 1 2 2 3 1 12 2 3 1 1 1 6 2 2 2 2 2 1 2 1 2 1 10 1 0
59 30 2 1 6 1 1 2 2 2 2 1 30 3 1 2 1 1 6 1 2 1 2 2 1 1 1 2 1 12 2 2
60 47 2 2 8 7 1 1 2 2 6 1 8 2 2 1 1 1 6 2 2 2 2 2 2 2 1 2 1 8 1 0
61 54 2 1 1 1 1 1 2 2 2 1 30 3 1 1 1 1 7 1 2 1 2 2 1 1 2 1 1 10 1 3
62 32 2 1 1 1 1 1 2 2 3 1 16 2 1 1 1 1 6 1 2 1 1 2 1 1 2 2 1 8 1 2
63 35 2 3 3 2 1 1 2 2 2 1 12 2 3 1 1 1 7 2 2 1 2 2 1 1 1 1 1 14 2 0
64 61 2 1 3 8 1 1 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 2 1 2 8 1 1
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65 45 2 3 1 2 1 1 2 2 5 1 8 2 3 1 1 1 5 2 2 2 2 2 1 2 2 2 1 12 2 0
66 36 2 2 8 3 1 1 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 6 1 0
67 65 2 1 3 2 1 1 2 2 4 1 16 2 1 1 1 1 6 2 2 2 2 2 1 2 2 2 1 15 2 0
68 40 2 3 1 2 1 1 2 2 3 1 12 2 3 1 1 1 7 2 2 2 2 2 1 2 2 2 1 12 2 0
69 28 2 2 8 3 1 1 2 1 5 1 8 2 2 1 1 1 6 2 2 2 2 2 1 2 1 2 2 12 2 0
70 35 2 3 6 1 1 2 2 2 2 1 12 2 1 2 1 1 6 2 2 2 2 2 1 1 1 2 1 8 1 2
71 32 2 2 7 6 1 1 2 2 5 1 8 2 2 1 1 1 6 2 2 1 2 2 1 1 2 2 1 6 1 0
72 70 2 1 1 2 1 1 2 2 3 1 8 2 1 1 1 1 5 2 2 2 2 2 1 2 2 2 1 9 1 0
73 42 2 1 3 2 1 1 2 2 4 1 12 2 1 1 1 1 7 2 2 1 2 2 1 1 2 2 1 10 1 0
74 12 2 3 6 1 1 2 2 2 3 1 30 3 1 2 1 1 6 1 2 1 2 2 1 1 1 2 1 10 1 2
75 58 2 1 3 8 1 1 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 2 1 2 6 1 1
76 50 2 1 3 1 1 1 2 2 2 1 30 3 1 1 1 1 7 1 2 1 1 1 1 1 2 1 1 12 2 2
77 42 2 3 6 7 1 2 2 2 3 1 12 2 2 2 1 1 7 2 2 1 1 2 1 1 1 2 1 9 1 1
78 40 2 3 1 2 1 1 2 2 3 1 12 2 3 1 1 1 6 2 2 2 2 2 1 2 2 2 1 10 1 0
79 52 2 3 6 4 2 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 6 1 0
80 55 2 1 2 2 1 1 2 2 3 1 4 1 3 1 1 1 5 1 2 2 2 2 1 1 1 1 1 16 2 0
81 45 2 1 1 2 1 1 2 2 5 1 12 2 1 1 1 1 6 2 2 2 2 2 1 1 2 2 1 9 1 0
82 42 2 3 1 1 1 1 2 2 4 1 12 2 3 1 1 1 6 2 2 1 2 1 1 1 2 1 1 10 1 2
83 48 2 3 1 2 1 1 2 2 3 1 12 2 3 1 1 1 4 1 2 2 2 2 1 1 2 2 1 12 2 0
84 21 2 2 8 3 1 1 2 2 5 1 12 2 2 1 1 1 6 2 2 2 2 2 1 2 1 2 1 10 1 0
85 45 2 3 3 6 1 1 2 2 6 1 12 2 3 1 1 1 7 2 2 2 2 2 1 2 2 2 1 8 1 0
86 85 2 1 1 2 1 1 2 2 4 1 8 2 1 1 1 1 5 2 2 2 2 2 1 2 2 2 1 12 2 0
87 22 2 3 6 6 1 2 2 2 6 1 8 2 1 2 1 1 4 2 2 2 2 2 1 2 2 2 1 6 1 0
88 57 2 3 4 2 1 1 2 2 6 1 16 2 3 1 1 1 6 2 2 1 2 2 1 2 2 2 1 10 1 0
89 53 2 3 6 4 1 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 2 2 2 8 1 0
90 19 2 1 3 2 1 1 2 1 3 1 8 2 1 1 1 1 5 2 2 2 2 2 1 2 2 2 1 12 2 0
91 33 2 1 3 8 1 1 2 2 1 1 30 3 1 1 1 1 6 2 2 2 2 2 1 2 2 1 1 8 1 1
92 53 2 3 6 4 1 2 2 2 4 1 12 2 3 2 1 1 4 2 2 2 2 2 1 2 1 2 2 8 1 0
93 32 2 1 3 1 1 1 2 2 4 1 16 2 1 1 1 1 7 1 2 2 1 1 2 1 2 1 1 12 2 2
94 35 2 1 3 1 1 1 2 2 1 1 30 3 1 1 1 1 6 1 2 1 1 1 1 1 2 1 1 18 2 2
95 32 2 2 7 5 1 1 2 2 4 1 12 2 2 1 1 1 6 2 2 1 2 2 2 1 2 2 1 8 1 0
96 16 2 2 7 6 1 2 2 2 3 1 12 2 2 2 1 1 6 1 2 1 1 2 2 1 1 2 1 10 1 0
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97 60 2 1 3 2 1 1 2 2 3 1 12 2 3 1 1 1 5 2 2 2 2 2 1 2 2 2 1 9 1 1
98 18 1 2 11 6 1 1 2 2 4 1 12 2 1 1 1 1 5 2 2 1 2 2 1 1 2 2 1 9 1 0
99 16 1 1 1 6 1 1 2 2 2 1 12 2 1 1 1 1 5 2 2 2 2 2 1 2 1 2 1 16 2 0
100 17 1 2 7 5 1 2 2 2 1 1 12 2 2 2 1 1 6 1 2 1 2 2 1 1 1 2 1 12 2 1
101 17 1 3 7 5 1 1 2 2 1 1 12 2 3 1 1 1 8 1 2 1 2 2 1 1 2 2 1 24 3 1
102 60 1 3 6 9 1 2 2 2 6 1 12 2 3 2 1 1 6 2 2 1 2 2 1 1 1 2 1 12 2 1
103 53 1 3 1 2 1 1 2 2 4 1 12 2 3 1 1 1 6 2 2 2 2 2 1 2 2 2 1 18 2 0
104 30 2 1 4 1 1 1 2 1 1 1 8 2 1 1 1 1 5 2 2 2 2 2 1 2 2 1 1 18 2 2
105 50 2 1 6 4 1 2 2 2 1 1 8 2 2 2 1 1 5 2 2 2 2 2 1 2 1 2 1 22 3 0
106 44 2 1 6 4 1 2 2 2 2 1 8 2 1 2 1 1 5 1 2 1 2 2 1 1 1 2 1 12 2 0
107 60 1 3 3 1 1 1 2 2 2 1 30 3 3 1 1 1 7 2 2 1 2 2 1 2 1 2 1 12 2 2
108 15 1 1 1 7 2 1 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 2 1 2 20 2 1
109 40 2 1 3 1 1 1 2 2 3 1 12 2 1 1 1 1 6 2 2 2 2 2 1 2 2 1 1 12 2 2
110 43 2 1 3 2 1 1 2 2 5 1 12 2 1 1 1 1 5 2 2 2 2 2 1 2 2 2 1 12 2 0
111 15 2 1 6 4 1 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 8 1 0
112 46 2 1 6 4 1 2 2 2 4 1 8 2 1 2 1 1 4 2 2 2 2 2 1 2 1 2 1 9 1 0
113 55 2 1 6 4 1 2 2 2 1 1 12 2 1 2 1 1 5 2 2 2 2 2 1 2 1 2 1 9 1 0
114 32 2 1 2 1 1 1 2 2 2 1 12 2 1 1 1 1 6 2 2 2 2 2 1 1 2 2 1 8 1 2
115 35 2 3 10 7 1 1 2 2 3 1 12 2 1 1 1 1 6 2 2 2 2 2 1 2 2 2 1 6 1 1
116 35 2 3 6 4 1 2 2 2 3 1 8 2 1 2 1 1 5 2 2 2 2 2 1 2 1 2 1 10 1 0
117 23 2 1 6 4 1 2 2 2 4 1 8 2 1 2 1 1 4 2 2 2 2 2 1 2 1 2 1 8 1 0
118 39 2 1 5 1 1 1 2 2 5 1 16 2 1 1 1 1 6 2 2 2 2 2 1 2 1 2 1 8 2 1
119 40 2 1 6 2 1 2 2 2 3 1 8 2 1 2 1 1 5 2 2 2 2 2 1 2 2 2 1 9 1 1
120 36 2 1 3 1 1 1 2 2 3 1 12 2 1 1 1 1 6 2 2 2 2 2 1 1 2 1 1 8 1 2
121 24 1 3 7 5 1 1 2 2 3 1 12 2 3 1 1 1 7 1 2 1 1 2 2 1 2 2 1 20 2 0
122 21 2 1 5 2 1 1 2 2 5 1 12 2 1 2 1 1 5 2 2 2 2 2 1 1 2 2 1 8 1 0
123 20 1 1 1 2 1 1 2 2 4 1 12 2 1 1 1 1 6 2 2 2 2 2 1 2 2 2 1 10 1 0
124 53 1 1 1 2 1 1 2 2 6 1 8 2 1 1 1 1 5 2 2 2 2 2 1 2 2 2 1 8 1 0
125 30 1 2 8 3 1 1 2 2 6 1 12 2 2 1 1 1 6 2 2 2 2 2 1 2 1 2 1 12 2 0
126 34 1 2 1 1 1 1 2 2 3 1 16 2 1 1 1 1 7 1 2 1 2 1 1 1 2 1 1 16 2 2
127 13 1 3 3 2 1 1 2 2 6 1 12 2 3 1 1 1 6 2 2 2 2 2 1 2 2 2 1 10 1 0
128 70 1 3 6 4 1 2 2 2 5 1 12 2 1 2 1 1 5 2 2 2 2 2 1 2 1 2 1 8 1 0
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129 24 1 1 1 2 1 1 2 2 6 1 12 2 1 1 1 1 5 2 2 2 2 2 1 2 2 2 1 12 2 0
130 18 1 1 1 10 1 1 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 2 1 2 8 1 0
131 53 1 3 6 9 1 2 2 2 3 1 12 2 2 2 1 1 6 2 2 1 2 2 1 1 1 2 1 8 1 1
132 21 1 1 6 4 1 2 2 2 5 1 8 2 1 2 1 1 5 2 2 2 2 2 1 2 1 2 1 10 1 0
133 32 1 1 6 4 1 2 2 2 4 1 12 2 1 2 1 1 4 2 2 2 2 2 1 2 1 2 1 9 1 0
134 60 1 1 6 9 1 2 2 2 2 1 12 2 2 2 1 1 6 2 2 1 2 2 1 1 1 2 1 9 1 1
135 55 1 2 8 3 1 1 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 6 1 0
136 39 1 1 2 2 1 1 2 2 5 1 12 2 1 1 1 1 6 2 2 2 2 2 1 2 2 2 1 10 1 0
137 55 1 3 1 1 1 1 2 2 4 1 12 2 3 1 1 1 7 2 2 1 2 2 1 1 1 1 1 9 1 2
138 70 1 2 9 8 1 1 2 2 1 1 30 3 2 1 1 1 7 1 2 1 2 2 1 1 1 2 1 12 2 1
139 24 1 1 1 10 1 1 2 2 3 1 12 2 1 1 1 1 4 2 2 2 2 2 1 2 2 2 1 8 1 0
140 22 1 3 3 2 1 1 2 2 6 1 12 2 3 1 1 1 5 1 2 1 2 2 1 1 2 2 1 10 1 0
141 35 1 1 6 4 1 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 9 1 0
142 65 1 3 1 2 1 1 2 2 4 1 12 2 3 1 1 1 6 2 2 2 2 2 1 2 2 2 1 8 1 0
143 70 1 3 2 8 1 1 2 2 1 1 30 3 3 1 1 1 6 2 2 2 2 2 1 2 2 1 1 10 1 1
144 65 2 1 3 2 1 1 2 2 4 1 12 2 1 1 1 1 7 1 2 1 2 1 1 1 2 2 1 14 2 0
145 18 2 2 11 7 1 1 2 2 5 1 12 2 2 1 1 1 6 2 2 2 2 2 1 1 2 2 1 8 1 0
146 60 2 3 1 1 1 1 2 2 3 1 30 3 3 1 1 1 7 1 2 1 2 1 1 1 2 1 1 12 2 3
147 45 2 1 6 4 1 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 8 1 0
148 18 2 2 7 6 1 2 2 2 2 1 30 3 2 2 1 1 7 1 2 1 2 2 1 1 2 2 1 10 1 0
149 30 2 1 4 1 1 1 2 2 1 1 12 2 1 1 1 1 5 2 2 2 2 2 1 2 2 1 1 18 2 2
150 60 2 1 3 2 1 1 2 2 5 1 12 2 1 1 1 1 6 2 2 1 2 2 1 2 2 2 1 8 1 0
151 75 2 1 3 1 1 1 2 2 2 1 16 2 1 1 1 1 7 1 2 1 2 2 1 1 2 1 1 10 1 2
152 45 2 1 6 4 1 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 8 1 0
153 16 2 1 10 1 1 1 2 2 3 1 16 2 1 1 1 1 6 2 2 1 2 2 1 1 1 2 1 9 1 3
154 55 2 1 3 2 1 1 2 2 5 1 12 2 1 1 1 1 5 2 2 2 2 2 1 2 2 2 1 8 1 0
155 55 2 3 4 1 1 1 2 2 2 1 30 3 1 1 1 2 6 2 2 1 2 2 1 1 1 2 1 9 1 0
156 65 2 2 11 7 1 1 2 2 6 1 12 2 2 1 1 1 5 2 2 2 2 2 2 2 2 2 1 10 1 0
157 70 2 1 2 8 1 1 2 2 2 1 16 2 1 1 1 1 6 1 2 2 2 2 1 1 1 1 1 12 2 2
158 45 2 1 1 1 1 1 2 2 2 1 30 3 1 1 1 1 7 1 2 1 1 1 2 1 2 1 1 12 2 3
159 58 2 3 3 2 1 1 2 2 5 1 12 2 3 1 1 1 6 2 2 2 2 2 1 2 2 2 1 8 1 0
160 15 2 1 6 6 1 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 8 1 0
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161 55 2 3 10 1 1 1 2 2 4 1 12 2 3 1 1 1 6 2 2 1 2 2 1 1 1 2 1 8 1 2
162 45 2 1 1 8 1 1 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 2 1 2 6 1 1
163 55 2 1 3 2 1 1 2 2 6 1 12 2 1 1 1 1 6 2 2 2 2 2 1 2 2 2 1 10 1 0
164 38 2 3 1 2 1 1 2 1 4 1 12 2 3 1 1 1 6 2 2 2 2 2 1 2 2 2 1 8 1 0
165 53 2 1 6 9 1 2 2 2 5 1 12 2 2 2 1 1 6 1 2 1 2 2 1 1 1 2 1 10 1 1
166 46 1 3 3 1 1 1 2 2 2 1 16 2 3 1 1 2 6 1 2 1 2 1 1 1 2 1 1 12 2 2
167 40 1 1 6 4 1 2 2 2 5 1 12 2 1 2 1 1 5 2 2 2 2 2 1 2 1 2 1 10 1 0
168 27 1 3 3 2 1 1 2 2 6 1 8 2 3 1 1 1 6 2 2 2 2 2 1 2 2 2 1 8 1 0
169 60 1 1 1 1 1 1 2 2 2 1 30 3 1 1 1 1 7 1 2 1 1 1 2 1 2 1 1 12 2 3
170 45 1 2 7 6 1 2 2 2 3 1 12 2 2 2 1 1 7 2 2 1 2 2 2 1 2 2 1 9 1 0
171 30 1 3 1 2 1 1 2 2 5 1 12 2 3 1 2 1 5 2 2 1 2 2 1 1 2 2 1 16 2 0
172 15 1 1 1 2 1 1 2 2 4 1 16 2 1 1 1 1 6 2 2 2 2 2 1 2 2 2 1 12 2 0
173 41 1 3 6 9 1 2 2 2 4 1 12 2 2 2 1 1 7 1 2 1 2 2 1 1 1 2 1 12 2 1
174 80 1 1 4 1 1 1 2 2 2 1 12 2 1 1 1 1 5 1 2 2 2 1 1 1 2 2 1 15 2 2
175 67 1 1 6 4 1 2 2 2 6 1 12 2 2 2 1 1 5 2 2 2 2 2 1 2 1 2 1 12 2 0
176 60 1 1 3 1 1 1 2 2 3 1 12 2 1 1 1 1 6 2 2 1 2 2 1 1 2 2 1 9 1 2
177 49 1 2 7 6 1 2 2 2 4 1 12 2 2 2 1 1 6 1 2 1 1 2 2 1 1 2 1 10 1 0
178 35 1 1 1 1 1 1 2 2 3 1 16 2 1 1 1 2 7 1 2 1 1 1 2 1 2 1 1 10 1 3
179 32 1 1 3 2 1 1 2 2 6 1 12 2 1 1 1 1 5 2 2 2 2 2 1 2 2 2 1 10 1 0
180 28 1 1 6 1 1 2 2 2 3 1 30 3 2 2 1 1 7 1 2 1 2 2 2 1 1 2 1 9 1 2
181 48 1 3 3 1 1 1 2 2 3 1 16 2 3 1 1 1 6 2 2 1 2 2 1 1 2 2 1 9 1 2
182 65 1 1 1 1 1 1 2 2 4 1 12 2 1 1 1 1 6 2 2 2 2 2 1 2 2 2 1 8 1 1
183 45 1 2 7 5 1 2 2 2 2 1 12 2 2 2 1 1 6 1 2 1 2 2 2 1 2 2 1 10 1 0
184 32 1 3 3 1 1 1 2 2 2 1 12 2 3 1 1 1 5 1 2 1 2 2 1 1 2 2 1 8 1 2
185 26 1 1 6 1 1 2 2 2 2 1 30 3 2 2 1 1 6 2 2 1 2 2 1 2 1 2 1 8 1 2
186 34 1 2 11 7 1 1 2 2 2 1 8 2 2 1 1 1 5 2 2 2 2 2 2 1 2 2 1 6 1 0
187 30 1 3 1 1 1 1 2 2 4 1 16 2 3 1 1 1 6 1 2 1 2 1 1 1 2 2 1 9 1 2
188 40 2 1 6 9 1 2 2 2 4 1 12 2 2 2 1 1 6 1 2 2 2 2 1 1 1 2 1 9 1 1
189 35 2 3 4 2 1 1 2 2 5 1 12 2 3 1 1 1 6 2 2 2 2 2 1 2 2 2 1 8 1 0
190 43 2 1 6 4 1 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 9 1 0
191 14 2 1 6 1 1 2 2 2 2 1 30 3 2 2 1 1 6 1 2 1 1 2 2 1 1 2 1 12 2 2
192 32 2 2 7 6 1 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 8 1 0
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193 18 2 1 4 2 1 1 2 2 6 1 12 2 1 1 1 1 7 2 2 2 2 2 1 2 2 2 1 12 2 0
194 39 2 3 3 1 1 1 2 2 4 1 12 2 3 1 1 1 6 1 2 1 2 2 2 1 2 2 1 10 1 2
195 75 1 1 6 1 1 2 2 2 3 1 30 3 2 2 1 1 6 2 2 1 2 2 1 2 1 2 1 9 1 2
196 58 1 1 3 8 1 1 2 2 1 1 30 3 1 1 1 1 6 2 2 2 2 2 1 2 1 2 1 8 1 2
197 58 1 1 4 1 1 1 2 2 4 1 12 2 1 1 1 1 6 2 2 1 2 2 1 2 2 2 1 9 1 2
198 27 1 3 3 2 1 1 2 2 7 1 12 2 3 1 2 1 6 2 2 2 2 2 1 2 2 2 1 12 2 0
199 52 1 1 1 1 1 1 2 2 3 1 16 2 1 1 1 2 7 1 2 1 1 1 2 1 2 1 1 20 2 2
200 60 1 3 1 1 1 1 2 2 3 1 12 2 3 1 1 1 6 1 2 2 2 2 1 1 2 1 1 14 2 2
201 30 1 1 3 1 1 1 2 1 4 1 16 2 1 1 1 1 6 2 2 2 2 2 1 2 2 2 1 9 1 2
202 60 1 3 1 2 1 1 2 2 6 1 12 2 3 1 2 1 6 2 2 2 2 2 1 2 2 2 1 10 1 0
203 20 1 2 7 6 1 2 2 2 3 1 12 2 2 2 1 1 6 1 2 1 2 2 1 1 1 2 1 9 1 0
204 13 1 3 1 2 1 1 2 2 6 1 12 2 3 1 1 1 6 2 2 2 2 2 1 2 2 2 1 10 1 0
205 50 1 3 6 4 2 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 9 1 0
206 45 1 2 7 6 1 2 2 2 4 1 12 2 2 2 1 1 6 1 2 1 2 2 1 1 2 2 1 10 1 0
207 13 1 3 1 8 1 1 2 2 3 1 12 2 3 1 1 1 6 2 2 2 2 2 1 2 2 1 1 8 1 1
208 53 1 1 6 4 2 2 2 2 0 #### ### #### #### ### ### #### #### ### ### ### ### ### ### 2 1 2 2 8 1 0
MASTER CHART NUMBER CODE REFERENCE 
Number code used 1 2  3 4 5 6  7 8 9 10 11 
Sex  Male female     
Side of tumour  Left Midline  Right    
Location  Frontal Frontoparietal Parietal Temporal Occipital CP angle Ventricular Sellar multiple Thalamic pineal 
Type of tumour  Glioma Meningioma Macroadenoma,
cranipharyngioma
Schwanoma Ependymoma Cyst  SOL unclassified Secondaries Haemangioblastoma Cavernoma   
Headache  Present Absent     
Tentorial reference Supra tentorial  infratentoprial    
Family History  Yes no     
Prior headache  Yes no     
Duration in months Same number       
Cont or 
intermittent 
Intermittent  continuous    
Episode frequency 
(per month) 
Same number       
Duration of 
episodes(in hrs) 
< 4 hrs 4 to 24 hrs >24 hrs    
HA side  Left Bilateral  right    
HA location  Frontoparietal  Occipital     
Progression  Generalized  unilateral    
Quality  Dull Band like    
intensity  Corresponding 
numerical
     
Nausea vomitting  Yes no     
photophobia  Yes no     
Worsening with 
cough 
Yes no     
Worsening with 
strain 
Yes no     
Worsening with 
posture 
Yes no     
Early morning 
headache 
Yes no     
Raised ICP  Yes no     
Focal deficit  Yes no     
Seizure  Yes no     
Medication 
requiring 
Yes no     
Tumour size  <10 cm 2 10 ‐20 cm 2 >20 cm 2    
Tumour edema  0 1(mild)  2(mod) 3(severe)    
   

     Abstract 
The temporal profile of (space occupying lesion of brain) tumour headaches 
Introduction: 
Given the range of disorders that are implicated in manifesting as headache, 
an analysis and interpretation of  the pattern of headache would be helpful in 
identifying rarer life threatening secondary headaches. This study is, planned mainly 
to analyse the pattern of the  secondary headaches due to brain neoplasm. 
Methods: 
All the Patients diagnosed to have primary or secondary brain tumour by 
neuroimaging were interviewed in detail about the headache. Clinical , 
neuroimaging and biopsy details were obtained. 
Results: 
The prevalence of headache in the study population of 208 patients was 88.5 %. 
Most had a change in  the pattern of headache  among 3.8 % who had pre existing 
headache.During onset, Headaches were localized to  frontoparietal  in 
supratentorial, and bifronto parietal  in sellar and in hydrocephalus , bioccipital in  
infratentorial tumours  and to the same side in hemispheric lesions. 97.3% had dull 
aching   quality. Greater intensity were seen in with more number of patients with 
raised Intracranial pressure group, with tumor with edema. The frequency of 
episodes were more in the severe edema group. 
Discussion: 
The brain tumour associated headache initially  has onset in the side of tumour in 
hemispheric lesions and bifrontal in pitutary tumours and in patients with raised 
ICP. The common pattern was of intermittent type of moderate intensity with 
worsening with valsalva and postural change. The size of the tumour  is one of the 
factor requiring modification by other factors like edema, development of  raised 
ICP, vascular or meningeal involvement, etc. in determining the headache. The 
extent of edema plays a significant role with regard to intensity and frequency of the 
episodes per month.  
Conclusion: 
The brain tumour associated headaches have special characteristic  features 
of  unilaterality, dull ache, recent onset or change in pattern with pre existing 
headache, progressive in nature, headache intensity worsening with valsalva, change 
in position or during exertion and  in association with seizures or neurological 
deficits. The infratentorial location, extent of tumour associated edema, and raised 
intracranial pressure are significantly important factors in brain tumour associated 
headache. 
Key words: ‘brain tumour’ ‘headache’ ‘brain SOL’  
